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Abstract
The national burden of Neonatal Abstinence Syndrome on individuals, families,
and the healthcare system has reached epidemic proportion. The rising incidence of
Neonatal Abstinence Syndrome significantly impacts healthcare utilization and costs due
to increases in Neonatal Intensive Care Unit admissions and length of hospitalization, to
the possible detriment of maternal-infant bonding. Because nonpharmacologic nursing
care is not complicated by the potentially harmful side effects of pharmacological
treatment, it should be considered the standard of care for opioid-exposed infants;
therefore, a comprehensive understanding of the barriers and enablers to nurses’
implementation of nonpharmacological interventions for infants with Neonatal
Abstinence Syndrome is needed.
This dissertation examines the benefits and factors associated with breastfeeding
(a key nonpharmacological intervention) for the opioid-dependent maternal-infant dyad,
factors associated with influencing healthcare providers’ behaviors in the care of infants
with Neonatal Abstinence Syndrome, and barriers and enablers to nurses’ implementation
of nonpharmacological interventions for infants with Neonatal Abstinence Syndrome.
Findings from this study will inform the development of programs to improve nurses’
implementation of nonpharmacological interventions and health and utilization outcomes
in infants with Neonatal Abstinence Syndrome.
Keywords
Neonatal Abstinence Syndrome; neonatal withdrawal; Theoretical Domains Framework;
nonpharmacological interventions; nursing interventions; length of stay
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Introduction
The burden of Neonatal Abstinence Syndrome (NAS) on individuals, families,
and the healthcare system has reached epidemic proportions. NAS, a drug withdrawal
syndrome that most frequently occurs in infants with intrauterine exposure to opioids (1),
results in prolonged hospitalization and a wide array of deleterious symptoms requiring
extensive pharmacological treatment (2). In 2016, the overall incidence rate of NAS was
6.7 per 1000 in-hospital births with hospital costs totaling $572.7 million (1). The
majority of hospital costs (83%) were covered by Medicaid, indicating a disproportionate
financial burden on state and federal budgets (1).
Admissions of infants with NAS to neonatal intensive care units (NICUs)
increased from 7 per 1000 admissions in 2004 to 27 per 1000 admissions in 2013, with an
associated increase in the average length of stay (LOS) from 13 to 19 days (3). In 2012,
the average LOS for infants with NAS was 17 days and if pharmacologic treatment was
required, the average LOS increased to 23 days (4). Prolonged hospitalization separates
the mother from her infant during a critical time and impairs bonding, which is associated
with negative developmental and behavioral outcomes (5).
On a national level, this epidemic significantly impacts healthcare systems, as
studies have shown intrauterine exposure to opioids is associated with intrauterine growth
restriction, congenital anomalies, prematurity, low birth weight, and NAS (6). In the US,
the federal government introduced the 2015 Protecting Our Infants Act (S.799), with the
objectives of improving NAS surveillance programs, addressing research gaps, and
implementing effective measures for education, prevention, and treatment (7). The US
1

Department of Health and Human Services determined that gaps in research were related
to “the most appropriate treatment and management of infants with NAS” (S.799). In
response to this gap in research and to address the objectives of the Protecting Our
Infants Act, the dissertation study presented in this compendium was designed to inform
the development of programs to improve nurses’ implementation of nonpharmacological
interventions and health and utilization outcomes in infants with NAS.
The implementation of standardized protocols for NAS management is associated
with decreased LOS and hospital costs (8,9). The American Academy of Pediatrics
(AAP) Committee on Drugs recommends the establishment of an evidence-based
protocol guiding the assessment and management of infants diagnosed with NAS or those
at high risk for withdrawal (2). Although current NAS screening, assessment, and
treatment methods have limitations, the AAP committee recommends all clinicians be
educated on the application of validated withdrawal assessment tools (2). However, the
assessment and care management of infants with NAS varies widely among hospitals in
the US, and existing protocols have been based on minimal empirical data (10). In a
recent survey of accredited US neonatology fellowship programs, only 55% had
implemented a written NAS management protocol, and only 69% used a published
abstinence scoring system to determine the severity of withdrawal and inform the
treatment provided (11). In addition, new research findings are often not disseminated to
clinicians and therefore not implemented into practice (12). As a result, infants with NAS
may not receive the recommended course of treatment and may instead receive
unnecessary, ineffective, or even harmful therapies (12).
2

Experts recommend treating the maternal-infant dyad as the standard of care as
opposed to treating the infant with NAS alone (13-15). The nurse’s role is to properly
assess and interpret the infant’s behaviors, determine how the mother understands and
responds to her infant, and tailor interventions that help the mother care for her infant
(16). However, even though nurses are well-positioned to have a positive influence on the
maternal-infant dyad, they often exhibit judgmental behaviors because of negative
stereotypes about opioid-dependent mothers (16). In addition, maternal feelings of fear,
guilt, and shame related to drug use often limit the mother’s ability to have honest
conversations with nurses (17). Further, nurses often lack the required knowledge to
provide optimal care to the maternal-infant dyad, a barrier that may also limit the
development of nurse-mother relationships (18). To address these challenges, nurses
providing care for infants with NAS should receive specialized training that addresses all
facets of nursing care, including detailed information on adult addiction and drug use
during pregnancy, maternal attachment behaviors, encouragement of appropriate
maternal behavior, and breastfeeding when appropriate (17,19). This dissertation study is
significant because findings can inform the development and implementation of
specialized programs for nonpharmacological nursing interventions to improve outcomes
for the maternal-infant dyad, such as supporting breastfeeding when appropriate, caring
for the maternal-infant dyad, and promoting nurse-mother relationships (16,19,20).
Specific Aims
This dissertation examines nurses’ perceptions of barriers and enablers to
implementation of nonpharmacological interventions for infants with NAS. The three
3

manuscripts included in this study identify strategies for nurses to implement best
practice standards, nonpharmacological interventions, and clinical practice guidelines
(CPGs) in the care of infants with NAS and their families.
Aim 1: Examine benefits and factors associated with breastfeeding (a key
nonpharmacological intervention) for the opioid-dependent maternal -infant dyad.
The first manuscript is a scoping review to explore what is known about the
benefits of maternal breastmilk for the opioid-dependent maternal-infant dyad and to
evaluate factors related to breastfeeding implementation by opioid-dependent maternalinfant dyads guided by the SEM. The key findings from this scoping review identified the
importance of treating the infant with NAS as part of the maternal-infant dyad. Despite
recommendations for mothers in treatment to breastfeed their infants, many barriers
prevent mothers of infants with NAS from breastfeeding. Further, intentional, multi-level
interventions aimed at creating a more secure, compassionate, and comfortable
environment for the NAS maternal-infant dyad enhances outcomes for both mother and
infant.
Aim 2: Explore factors associated with influencing healthcare providers’ behaviors in
the care of infants with NAS.
The second manuscript is an integrative review, guided by the Whittemore and
Knafl methodology (21), on the current knowledge of the individual and contextual
factors that influence healthcare providers’ behaviors in implementing
nonpharmacological interventions to decrease LOS for infants with NAS through the lens
of the TDF. Key findings included: implementing evidence-based CPGs, which have
4

been shown to increase identification of infants with NAS, decrease NAS severity using
the Finnegan scoring tool, and decrease LOS; providing specialized training for
healthcare providers; including parents as integral care team members; utilizing
standardized withdrawal scoring tools; and including multidisciplinary care team
members in the care of infants with NAS to enhance overall outcomes for infants and
their families. In addition, the findings from the integrative review identified key
influential TDF domains which were further explored in the dissertation study.
Aim 3: Investigate barriers and enablers to nurses’ implementation of
nonpharmacological interventions for infants with NAS.
The third and final manuscript is a convergent parallel mixed methods study,
conducted through the lens of the TDF, which identified and prioritized barriers and
enablers of nurses’ implementation of nonpharmacological interventions for infants with
NAS. The findings from this study will inform the development of programs to improve
nurses’ implementation of nonpharmacological interventions in the care of this
vulnerable and rapidly growing patient population: the infant diagnosed with NAS.
Innovation
This parallel convergent mixed methods dissertation study exhibits two primary
innovations. It is the first to investigate barriers and enablers to nurses’ implementation of
nonpharmacological interventions for infants with NAS. A comprehensive representation
of nurses’ perspectives on the barriers and enablers to nurses’ implementation of
nonpharmacological interventions for infants with NAS was obtained through
administration of a tailored Determinants of Implementation Behavior Questionnaire
5

(DIBQ-NAS) to members of the National Association of Neonatal Nurses (NANN) and
semi-structured interviews with nurses. A second source of innovation is that this study
was the first to utilize the Theoretical Domains Framework (TDF) to guide the
exploration of nurses’ implementation of nonpharmacological interventions for infants
with NAS. The TDF provided a structure for assessing and evaluating the factors that
affect the behavior of healthcare providers and the implementation of evidence-based
practice (22, 23).
Theoretical Framework
The developers of the TDF identified 33 theories and 128 key theoretical
constructs associated with behavior change and synthesized them into one framework
that can be used to guide theoretical assessment of implementation problems, as well as
professional and other health-related behaviors as a basis for intervention development
(22). Knowledge, Skills, and Social/Professional Role and Identity are the domains with
greatest influence on providers’ implementation of nonpharmacological interventions to
decrease the LOS for infants with NAS (24). The Knowledge domain of the TDF includes
the following constructs: knowledge, knowledge about condition/scientific rationale,
schemas + mindsets + illness representations, and procedural knowledge (25). The Skills
domain of the TDF includes the following constructs: skills, competence/ability/skill,
assessment, practice/skills development, interpersonal skills, and coping strategies (25).
The Social/Professional Role and Identity domain of the TDF includes the following
constructs: identity, professional identity/boundaries, role, group/social identity,
social/group norms, and alienation/organizational commitment (25). In the integrative
6

review, the primary themes identified within these domains included: knowledge of NAS
and AAP (American Academy of Pediatrics) recommendations regarding the
management of NAS, nursing competence (assessment skills and effective utilization of
the Finnegan scoring tool), development of interpersonal relationships with parents
within professional boundaries, establishment of role within a multidisciplinary team, and
leadership in the management and care of infants with NAS. In addition to the
Knowledge, Skills, and Social/Professional Role and Identity domains, this study
investigated other influential contextual and environmental domains, such as Beliefs
about Capabilities, Environmental Context and Resources, Organization, and Emotion,
related to infants with NAS and the nurses who care for the NAS maternal-infant dyad.
Research Approach
In preparation for this dissertation study, a scoping review was conducted to
explore benefits of maternal breastmilk and to evaluate factors related to breastfeeding
implementation by opioid-dependent maternal-infant dyads guided by the Social
Ecological Model (SEM). In addition, a small pilot study was conducted to explore
nurses’ and other key interdisciplinary team members’ perceptions of the treatment plan
and care provided for infants with NAS. The findings from the pilot study were used to
inform and further refine the research design and methods for this dissertation study.
Further, an integrative review (24), guided by the constructs of the TDF, was
completed which focused on factors influencing healthcare providers’ behaviors in the
care of infants with NAS. Knowledge, Skills, and Social/Professional Role and Identity
were identified as being the most influential domains relevant to modifying healthcare
7

providers’ behaviors surrounding implementation of nonpharmacological interventions
aimed at decreasing the LOS for infants with NAS.
Finally, the dissertation study conducted through the lens of the TDF identified
and prioritized barriers and enablers of nurses’ implementation of nonpharmacological
interventions for infants with NAS. The findings from this study will inform the
development of programs to improve nurses’ implementation of nonpharmacological
interventions and health and utilization outcomes in infants with NAS.
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Manuscript 1
A Scoping Review of the Benefits of Breastmilk for the
Methadone Dependent Maternal-Infant Dyad
Abstract
Due to a significant increase in the number of infants diagnosed with neonatal abstinence
syndrome, it is important to develop a more comprehensive understanding of the health
implications of breastmilk provided by the mother. Therefore, the purpose of this scoping
review of literature is to explore what is known about the benefits of maternal breastmilk
for the opioid-dependent maternal-infant dyad, and to evaluate factors related to
breastfeeding implementation by opioid-dependent maternal-infant dyads guided by the
Social Ecological Model. The Social Ecological Model for health promotion is utilized as
the theoretical framework for this study because it supports the concept of developing
health promotion interventions that focus on the person and environment. Results of this
review may provide knowledge to inform future interventions and assist in the
development and implementation of best practice standards, clinical practice guidelines,
and protocols to mitigate barriers that prevent opioid-dependent mothers from
breastfeeding. The need for extensive support must be emphasized to ensure high
initiation rates and long duration of breastfeeding, when appropriate, to improve the care
of this vulnerable and rapidly-growing patient population: the neonatal abstinence
syndrome maternal-infant dyad.
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Keywords
Neonatal Abstinence Syndrome; Neonatal Withdrawal; Methadone; Social Ecological
Model; Breastmilk; Breastfeeding; Maternal-Infant Bond; Length of Hospitalization
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Introduction and Background
The number of expectant mothers using opiates rose nearly five-fold from 2000 to
2009 (Patrick et al., 2012). Among neonates with in-utero exposure to opioids, an
estimated 60%-90% experience drug withdrawal, a condition defined as Neonatal
Abstinence Syndrome (NAS) (Ebner et al., 2007). NAS is characterized by a wide array
of signs and symptoms, including increased irritability, hypertonia, tremors, feeding
intolerance, emesis, watery stools, seizures, and respiratory distress, often requiring
prolonged hospitalization and extensive pharmacological therapy (American Academy of
Pediatrics Committee on Drugs, 1998). The use of pharmacological therapies is supported
by an extensive body of research that indicates opiates should be first-line treatment for
infants with NAS (American Academy of Pediatrics Committee on Drugs, 1998).
Currently, methadone maintenance therapy is the standard of care for mothers dependent
on opiates during the perinatal period and the only pharmaceutical treatment
recommended in the United States (Jarvis & Schnoll, 1994; National Consensus
Development Panel on Effective Medical Treatment of Opiate Addiction, 1998).
Methadone maintenance therapy has successfully decreased the use of other opiates and
illicit drugs and the risk of infant loss, while increasing utilization of prenatal care and
substance abuse counseling (Jones et al., 2010).
Although mothers undergoing methadone maintenance therapy have been
discouraged from breastfeeding in the past if the maternal methadone dose was above
20mg/day, the American Academy of Pediatrics (in 2001 and 2013) no longer lists
methadone at any dose as a breastfeeding contraindication. The nutritional and
15

immunologic benefits of breastmilk for optimal health and development for all infants are
well established (World Health Organization, n.d.). And while there is limited research
on how maternal breastmilk augments pharmacologic treatment in infants with NAS,
studies suggest ingestion of maternal breastmilk may be an independent predictor of
favorable response to methadone therapy for infants with NAS (Isemann, Meinzen-Derr,
& Akinbi, 2010; Welle-Strand et al., 2013; O’Connor, Collett, Alto, & O’Brien, 2013). In
fact, breastfeeding has been shown to act as an analgesic for infants and is an established
method for soothing agitated infants, thus potentially improving withdrawal symptoms in
infants with NAS (Gray, Miller, Philipp, & Blass, 2002).
Some research findings have shown that women who have breastfed and those
who have breastfed for longer periods of time have experienced less postpartum
depression (U.S. Department of Health and Human Services [DHHS], 2011). For women
with a history of substance abuse and prior psychiatric comorbidities, such as anxiety,
depression, bipolar disorder, or attention-deficit/hyperactivity disorder, a reduction in the
risk of postpartum depression may be critical (Pritham, 2013) because the connection
between opioid dependence and co-occurring psychiatric symptoms in pregnant women
who receive methadone maintenance therapy is significant (Benningfield et al., 2010).
The immediate effects of skin-to-skin contact and breastfeeding on maternal
bonding may deter maternal substance abuse relapse and enhance infant development
(Pritham, 2013). Early skin-to-skin contact after birth encourages breastfeeding and has
positive effects on maternal feelings toward their infant (AAP, 2012). Skin-to-skin
contact and breastfeeding stimulate the release of oxytocin in the mother’s brain, which
16

elicits maternal parenting behaviors (Moore, Anderson, & Bergman, 2007; Nagasawa,
Okabe, Mogi, & Kikusui, 2012). When oxytocin is released, pain, stress, and anxiety
behaviors are lessened, which allows the mother to be more attentive to her infant
(Nagasawa et al., 2012). In addition, the bonding that develops as a result of skin-to-skin
contact and breastfeeding provides the encouragement to continue breastfeeding, thereby
establishing lifelong health benefits for the mother and infant (Pritham, 2013).
Despite all the benefits breastfeeding offers to this population, breastfeeding
initiation among women in methadone treatment programs is low, with reports ranging
from 24%-46%, compared with the national initiation rate of 77% (Wachman, Byun, &
Philipp, 2010; CDC, 2012). In addition, lactation among women in methadone treatment
programs (Jansson, 2009) and maternal perceptions of the decision to breastfeed the
infant with NAS have been understudied. Due to a significant increase in the number of
infants diagnosed with NAS, it is important to develop a more comprehensive
understanding of the health implications of breastmilk provided by the mother. Therefore,
the purpose of this scoping review of literature is:
1. To explore what is known about the benefits of maternal
breastmilk for the opioid-dependent maternal-infant dyad.
2. To evaluate factors related to breastfeeding implementation by
opioid-dependent maternal-infant dyads guided by the Social
Ecological Model (SEM).
Theoretical Framework

17

The Social Ecological Model (SEM) for health promotion is utilized as the
theoretical framework for this study because it supports the concept of developing health
promotion interventions that focus on the person and environment (McLeroy, Steckler,
Bibeau, & Glanz, 1988). The SEM model posits that “appropriate changes in the social
environment will produce changes in individuals, and that the support of individuals in
the population is essential for implementing environmental changes” (McLeroy et al.,
1988, p. 351). The SEM intent is to mitigate unhealthy behaviors by aiming interventions
at several determining factors: intrapersonal (characteristics of individual, attitudes, and
behaviors); interpersonal (social support system including family, work associates and
friends); institutional (social institutions with organizational structure); community
(relationships among organizations, and informal networks within defined boundaries);
and public policy (local, state, national laws and policies) (McLeroy et al., 1988).
Figure 1 represents the relationship between the maternal-infant dyad and the five
levels of influence of the SEM. Applying the SEM is the first step in learning the best
methods for changing the environment to improve health. The intrapersonal factor
corresponds to the bond between mother and child, maternal self-efficacy, infant security,
and perceived maternal stigma. The interpersonal factor relates to maternal support,
family relationships, relationships developed through employment and/or education, and
relationships with healthcare providers. The institutional factor corresponds to the
maternal methadone inpatient treatment program, the hospital nursery where the infant is
admitted (while receiving care for Neonatal Abstinence Syndrome), and maternal
hospitalization. The community factor relates to the support the mother receives from
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community resources, such as, WIC (Women, Infants, and Children: Food and Nutrition
Service), prenatal care, and transportation services. The public policy factor corresponds
to policies that are aimed at supporting vulnerable populations (mother-infant dyad), such
as Medicare and Medicaid. Many governmental policies and programs have been created
to encourage breastfeeding, such as the implementation of the Baby Friendly Hospital
Initiative (BFHI) and the Federal Nursing Mother’s Program. Effective multi-level
interventions should aim to create conditions that allow the parent(s) to provide a safe,
nurturing, and stimulating environment for their infant.
Figure 1
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Methods
A scoping study is utilized when a specific research question has not been
identified and the intent is to review broader topics, regardless of study design (Arskey &
O’Malley, 2005). Arskey and O’Malley (2005) developed a specific approach to increase
reliability of findings and methodological rigor (Mays, Roberts, & Popay, 2001). This
five-stage process was utilized in conducting this scoping study. The Arskey and
O’Malley (2005) methodological framework includes establishing a research question;
determining pertinent studies; refining the selection of literature; charting the data; and
collating, summarizing and reporting the results.
During a consultation with a reference librarian at an academic medical center,
the following electronic databases were determined to be the most appropriate for this
scoping study: Scopus, PubMed, and EBSCOhost (see table 1). Each database was
searched utilizing the following terms: “Breastfeeding” and “Methadone.”
Table 1
Available databases on the EBSCOhost platform
EBSCOhost databases
CINAHL Complete; Academic Search Premier; Agricola; Alt HealthWatch; Newswires; Applied
Science & Technology Full Text (H.W. Wilson); CINAHL Plus with Full Text; Computer Source;
Criminal Justice Abstracts with Full Text; eBook Collection (EBSCOhost); Education Full Text
(H.W. Wilson); ERIC; European Views of the Americas: 1493 to 1750; Fuente Académica; Funk &
Wagnalls New World Encyclopedia; GreenFILE; Health Source - Consumer Edition; Health Source:
Nursing/Academic Edition; History Reference Center; Library Literature & Information Science
Index (H.W. Wilson); Library, Information Science & Technology Abstracts; MAS Ultra - School
Edition; MasterFILE Premier; MEDLINE; Middle Search Plus; Military & Government Collection;
Newspaper Source Plus; Primary Search; Professional Development Collection; PsycARTICLES;
Psychology and Behavioral Sciences Collection; PsycINFO; Regional Business News; Religion and
Philosophy Collection; Science Reference Center; Teacher Reference Center; TOPICsearch;
Vocational and Career Collection; Web News; AHFS Consumer Medication Information; American
Doctoral Dissertations, 1933 - 1955; eBook Academic Collection (EBSCOhost); Consumer Health
Complete - EBSCOhost;
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The inclusion criteria for the articles were the following: the English language,
peer reviewed journals, humans, and published between 2005 and 2019. The reference
lists of selected articles were also examined for principal sources and additional pertinent
articles.
During the first search of the electronic databases, 138 articles were retrieved.
After citations were reviewed, 52 articles were determined to be duplicates and therefore
removed. The remaining 86 articles’ abstracts were examined for relevance based on the
inclusion and exclusion criteria. Research articles specific to the benefits of breastmilk
for Neonatal Abstinence Syndrome infants and the maternal health benefits of
breastfeeding were included. Articles that contained findings extraneous to infant and
maternal health were excluded (n = 44). Of the remaining 42 full-text articles, 10 studies
met the inclusion criteria for the study sample.
A PRIMSA flow diagram of this process was developed (Appendix A) (Moher,
Liberati, Tetzlaff, & Altman, 2009) as The Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) statement was utilized in selecting articles that
were included in the study sample. In addition, a scoping review matrix (Appendix B)
was created to organize the selected articles by author, date, study purpose, study design,
level of evidence, setting, sample description, size, data collection methods, results, and
limitations, therefore completing Stage 4 of Arskey and O’Malley’s methodological
framework. The SEM was utilized to complete Stage 5 of the Arskey and O’Malley
methodological framework (2005).
Results
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The studies that met the inclusion and exclusion criteria (n = 10) were primarily
conducted in substance abuse treatment centers and hospitals; one study utilized a
qualitative, focus group design, one study utilized a three-part cohort design, six studies
utilized retrospective chart reviews, and two studies utilized a systematic review. The
studies utilized historical maternal and neonatal data, interviews, case note reviews, the
Finnegan NAS scoring tool, and literature reviews as data collection methods. A majority
of the peer-reviewed articles addressed the effects of feeding methods (specifically
breastfeeding) on the severity of NAS, management and treatment of NAS, and the
maternal experience of breastfeeding while receiving methadone treatment.
Social Ecological Model
Although none of the selected studies utilized the SEM as the framework for the
design, a majority of the studies specifically addressed the intrapersonal level of
influence (n = 8), interpersonal level (n = 1), institutional level (n = 5), community level
(n = 2), and public policy level (n = 2) (see table 2). None of the selected studies
referenced the incorporation of a specific theory, framework, or model.
Table 2
Author,
Date
AbdelLatif et al.,
2006
Bagley et
al., 2014

Study Purpose

SEM Level

To assess the effects of
breastmilk on the severity and
outcome of NAS
To examine evidence for NAS
tools, nonpharmacological
interventions, &
pharmacological management of
opioid-exposed infants
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SEM Influential
Factors
Intrapersonal Maternal-infant bond,
maternal self-efficacy,
& infant security
Intrapersonal Maternal-infant bond,
maternal self-efficacy,
& infant security
Institutional

Hospital protocols and
clinical practices

Demirci et
al., 2015

To explore the perceptions
surrounding breastfeeding
decisions and management
among pregnant and postpartum
women taking methadone

Intrapersonal Maternal-infant bond,
maternal self-efficacy,
infant security, &
maternal stigma
Interpersonal Maternal support,
relationships with
family and peers
Community

Dryden et
al., 2015

Hodgson
et al., 2012

Isemann et
al., 2011
McQueen
et al., 2011

Pritham,
2013

Wachman
et al., 2010

WIC, prenatal care, &
community support
services
To investigate factors associated Intrapersonal Maternal-infant bond,
with the development of NAS
maternal self-efficacy,
and to assess the implications for
& maternal stigma
healthcare resources of infants
born to drug-misusing women
Community support
Community services & outpatient
clinic care
To explore the effect of a
Intrapersonal Maternal-infant bond
rooming-in protocol on the need
& maternal selfto treat withdrawal in the opioidefficacy
exposed infant
Institutional Rooming-in program
within hospital setting
To identify maternal and
Intrapersonal Maternal-infant bond,
neonatal factors that impact
maternal self-efficacy,
response therapy for NAS
& infant security
To determine whether NAS
Intrapersonal Maternal-infant bond,
scores of infants exposed to
maternal self-efficacy,
methadone in-utero differed by
& infant security
infant feeding method
Public Policy Policies regarding
methadone and
breastfeeding to assist
health care providers
and mitigate
discrimination
To review literature regarding
Institutional Provision of education
the association of breastfeeding
by healthcare providers
and NAS severity, need for
in the hospital/nursery
pharmacological therapy, and
setting
length of stay
To determine breastfeeding rates Institutional Breastfeeding barrier:
among opioid-dependent women
Methadone treatment
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giving birth in a Baby-friendly
Hospital

programs
Public Policy

WelleStrand et
al., 2013

To examine the rate and duration
of breastfeeding in a cohort of
women in opioid maintenance
therapy and the effect of
breastfeeding on the incidence
and duration of NAS

Hospital
protocol/policy:
Breastfeeding and
Illicit Drug Use
Guidelines
Intrapersonal Maternal-infant bond,
maternal self-efficacy,
& infant security
Institutional

Provision of education
by healthcare providers
in the hospital/nursery
setting

Intrapersonal Factors
Intrapersonal factors were found to have the most significant impact on the health
outcomes of the mother and infant as they directly correspond to maternal-infant
bonding, maternal self-efficacy, infant security, and maternal stigma. A majority of the
studies focused primarily on the intrapersonal factors related to the initiation of
breastfeeding in the opioid-dependent maternal-infant dyad.
Abdel-Latif et al. (2006) addressed the intrapersonal factor of the SEM, finding
that mothers who elected to breastfeed were more likely to have received antenatal care,
or to admit to less polydrug use, and were less likely to be identified to child welfare
services as an at-risk parent, potentially enabling the mother to effectively soothe her
infant thereby reducing the infant’s Finnegan withdrawal scores. Abdel-Latif et al. (2006)
also found that fewer infants who received maternal breastmilk required pharmacologic
treatment for withdrawal (52.9% versus 79%, p < .001) and the average time to withdraw
occurred significantly later in infants who received maternal breastmilk compared with
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those who received formula (10 days versus 3 days; p < .001). In addition, the amount of
morphine administered for withdrawal was considerably lower in infants who received
maternal breastmilk compared with those who received formula (Abdel-Latif et al.,
2006). The overall treatment duration was approximately 20 days less for infants who
received maternal breastmilk (Abdel-Latif et al., 2006).
Bagley, Wachman, Holland, and Brogly (2014) found similar results in a
systematic review. Their findings indicated that breastfed infants experienced an overall
decrease in pharmacological treatment, length of pharmacological treatment (if required),
NAS scores, and length of hospitalization. Dryden, Young, Hepburn, and Mactier (2009)
determined that breastfeeding for 72 hours or greater was independently associated with
decreasing the odds of the infant receiving pharmacological therapy for NAS by half.
These findings are congruent with the results of a retrospective chart review conducted
by Hodgson and Abrahams (2012) indicating that breastfeeding corresponded with a
decrease of 79% (p < .001) in the odds of the infant receiving morphine therapy. In a
retrospective review, Isemann, Meinzen-Derr, and Akinbi (2011) also determined
maternal breastmilk feedings were associated with a shorter duration of pharmacological
therapy and length of stay compared with formula fed infants (12.5 days versus 18.5
days, p = 0.01). Similarly, in a cohort study Welle-Strand et al. (2013) found methadoneexposed infants receiving breastmilk had a significantly lower incidence of NAS
requiring pharmacological treatment (53%) than methadone-exposed infants not
receiving breastmilk (80%). Welle-Strand et al. (2013) also found breastfed infants had a
shorter duration of pharmacological therapy for NAS (28.6 days) compared with infants
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who were not breastfed (46.7 days, p < 0.05). Reducing the length of stay for infants with
NAS is critical because having the infant at home will enhance the maternal-infant bond
while providing a more natural environment conducive to breastfeeding (McQueen et al.,
2011).
Despite these potential benefits, barriers to breastfeeding, including concern of
transfer of hepatitis C to the infant through breastmilk may discourage mothers and
providers from pursuing breastfeeding in this population. These barriers include
perceived lack of time to breastfeed due to other responsibilities as well as concerns over
not having “enough” breastmilk, of infant latching difficulty, and of an infant receiving
too much methadone through the transfer of breastmilk (Demirci, Bogen, & Klionsky,
2015). However, in their qualitative focus group study of seven pregnant women and four
postpartum women receiving methadone maintenance therapy, Demirci et al. (2015)
found that motivating factors may help to overcome these barriers. Motivating factors
included the potential for enhanced maternal-infant bonding, perceived health benefits for
mother and infant, and a means of mitigating infant discomfort related to NAS
symptoms.
Interpersonal Factors
Interpersonal factors correspond to maternal support, relationships with family
members, relationships with work and school associates, and relationships with
healthcare providers. These interpersonal factors have been shown to influence the
implementation of breastfeeding in the vulnerable opioid-dependent maternal-infant
dyad. Demirci et al. (2015) identified the mother’s own mother as a source of
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breastfeeding knowledge and support; however, partners were perceived as sources of
both support and anxiety regarding the decision to breastfeed. The participants in the
study also identified peers as influential in their decision to breastfeed (Demirci et al.,
2015).
Institutional Factors
Several studies addressed the institutional factors that directly correspond to
methadone treatment programs and hospitals. In a systematic review, Bagley et al. (2014)
addressed the institutional factor of the SEM by recommending that hospitals align
clinical practices with standard protocols including the use of valid assessment measures,
accepted pharmacologic treatment (morphine and methadone), and specific training for
those delivering infant care. Evidence from two other studies suggests providing
education addressing the benefits of breastfeeding along with practical instruction on the
mechanics of breastfeeding may increase initiation rates (Pritham, 2013; Welle-Strand et
al., 2013). Bagley et al. (2014) posited that mothers in treatment programs may have
access to other healthcare services including counseling, infection screening, and fetal
growth monitoring, thereby enhancing maternal and infant outcomes. However, mothers
in treatment programs are also often required to attend group meetings, individual
therapy sessions, and make daily trips to the treatment center for medication and drug
testing, thereby limiting time with their infant (Wachman, Byun, & Philipp, 2010).
Another potential method to improve breastfeeding initiation rates in this
maternal-infant dyad is the development of a rooming-in program within the hospital
setting. In a retrospective chart review, Hodgson and Abrahams (2012) examined a
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rooming-in program to mitigate the need to treat infants for opiate withdrawal. Their
findings suggest that rooming-in is a safe alternative to the current standard of care that
separates mother and infant because it allows the mother to care for her infant and
provides an environment conducive to breastfeeding thereby enhancing the maternalinfant bond (Hodgson & Abrahams, 2012).
Community Factors
Two studies addressed the community factors that directly correspond to WIC,
prenatal care, transportation services, and civic organizations. Dryden et al. (2009)
conducted a retrospective cohort study addressing the implications for healthcare and
community resources dedicated to this vulnerable maternal-infant dyad. They posited that
the majority of drug-misusing mothers electing not to breastfeed did so due to “deeply
engrained social prejudices and not because of polydrug misuse” (Dryden et al., 2009, p.
669). Dryden et al. (2009) found that outpatient follow-up care was often unutilized by
this population due to their challenging and complex lifestyles. This finding suggests the
need for providing community support services with increased efforts to facilitate
interdisciplinary communication among service providers (Dryden et al., 2009).
The need for community support services is further emphasized by the findings of
Demirci et al. (2016) as women in methadone therapy obtained breastfeeding information
and misinformation within the health care community from WIC counselors and internet
resources; however, prenatal care providers rarely addressed breastfeeding.
Public Policy
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While none of the studies in this scoping review specifically addressed the role of
public policy as it related to the initiation of breastfeeding in the opioid-dependent
maternal-infant dyad, many of the studies collectively suggested that agency policies
regarding breastfeeding and methadone are needed to assist health care providers as they
deliver evidence-based care to mothers in methadone treatment who desire to breastfeed.
In addition, establishing breastfeeding policies for the opioid-dependent maternal-infant
dyad may mitigate the potential for discrimination based on the mothers’ use of
methadone (McQueen et al., 2011).
Wachman et al. (2010) discussed a hospital’s development of a multidisciplinary
task force aimed at creating Breastfeeding and Illicit Drug Use Guidelines. The intent of
the guidelines was to provide consistent care with an emphasis on the importance of
maternal sobriety and the provision of all possible supports for mothers choosing to
breastfeed.
Discussion
The primary finding of this scoping review is that, when possible, and if not
otherwise contraindicated, mothers who adhere to a supervised drug treatment program
should be encouraged to breastfeed as long as the infant continues to gain weight (AbdelLatif et al., 2006; Bagley et al., 2014; Demirci, et al., 2015; Dryden et al., 2009; Isemann
et al., 2011; McQueen et al., 2011; Pritham, 2013). Most of the studies included in this
review show that breastfeeding has been associated with less severe NAS that presented
later and required less frequent pharmacologic intervention, which resulted in fewer
hospital days for the infant (Abdel-Latif et al., 2006; Bagley et al., 2014; Hodgson &
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Abrahams, 2012; Isemann, et al., 2011; McQueen et al., 2011; Pritham, 2013; WelleStrand et al., 2013). Findings from published studies indicate that unnecessary
pharmacologic treatment will prolong drug exposure and the duration of hospitalization
to the possible detriment of maternal-infant bonding (Abdel-Latif et al., 2006; Hudak &
Tan, 2012; McQueen et al., 2011; Pritham, 2013). The findings also indicate that
breastfeeding provided optimal nutrition, promoted bonding, and empowered babies’
mothers to be effective parents (Legatte, 2008; Jambert-Gray et al., 2009; Jansson et al.,
2008; McQueen et al., 2011). In addition, Bagley et al. (2014) suggested that
breastfeeding and allowing the maternal-infant dyad to “room-in” increased bonding and
normalized the postpartum experience for mothers who may have felt vulnerable and
stigmatized due to their history of opioid dependence.
Demirci et al. (2015) identified peers as influential in maternal breastfeeding
decisions. This finding aligns with previous studies that suggest breastfeeding peer
support programs can increase breastfeeding initiation rates, duration, and exclusivity,
particularly for women who share unique breastfeeding concerns, such as those receiving
methadone treatment (Britton, McCormick, Renfrew, Wade, & King, 2007; Chung,
Raman, Trikalinos, Lau, & Ip, 2008; Fairbank et al., 2000). The most effective programs
included breastfeeding training, health care provider involvement, early support, and peer
assistants who shared a similar socio-economic background as the mothers they
counseled (Centers for Disease Control and Prevention, 2013).
Literature Gaps
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The vulnerable population of the maternal-infant dyad has unique benefits to gain
from breastfeeding due to the emotional, behavioral, and medical complications that
often affect them; however, lactation among women in methadone treatment programs
has been understudied (Jansson, 2009). Further, research dedicated to understanding
maternal perceptions of the decision to breastfeed the NAS infant is lacking, as is
research utilizing large-scale studies examining the effects of breastmilk on the severity
of NAS as determined by a quantitative withdrawal scale (Abdel-Latif et al., 2006). Also,
there is limited data on the inter-observer reliability of NAS assessment tools due to lack
of a standardized approach (Bagley et al., 2014). As Demirci et al. (2015) suggest, future
researchers should examine the feasibility and effectiveness of peer-based lactation
support within methadone treatment centers and hospitals caring for infants with NAS.
Isemann et al. (2011) argue that studies are needed to identify infants at risk for rebound
NAS, including correlation with serum (methadone) concentrations in breastmilk.
Finally, in future studies researchers should examine health care providers’ perceptions
regarding breastfeeding and mothers in methadone treatment programs.
Limitations
This scoping review provides a general overview of the available literature related
to the benefits of breastmilk for the opioid-dependent maternal-infant dyad and factors
related to breastfeeding implementation as guided by the SEM. Due to specific inclusion
and exclusion criteria, this scoping review is not inclusive of all available literature
related to this study topic. Also, a second researcher was not available to assist with the
literature review process and mitigate researcher bias as recommended by Arksey and
31

O’Malley (2005). Finally, due to the utilization of specific search terms in the initial
inquiry, additional articles related to the study topic may not have been discovered during
this scoping review.
Conclusions
As illustrated by the evidence included within this review, it is important to
consider the infant with NAS as part of a maternal-infant dyad as treatment for the infant
does not occur in isolation from the mother. Despite the recommendations for mothers in
treatment to breastfeed their infants, many barriers exist that prevent these mothers from
breastfeeding, including inconsistent advice from health care providers; lack of clear
guidelines; feeding problems (related to NAS); lengthy hospital stays that prohibit
maternal-infant bonding; and issues such as low self-esteem, lack of knowledge, or
feelings of maternal guilt (Dryden et al., 2009; McQueen et al., 2011; Jansson, Velez, &
Harrow, 2004). Health care providers must understand current guidelines for
breastfeeding among mothers in methadone treatment and offer these women
nondiscriminatory and supportive counsel regarding common breastfeeding barriers and
maternal concerns (Demirci et al., 2014). The need for extensive support must be
emphasized to ensure high initiation rates and long duration of breastfeeding, when
appropriate, for the benefit of the maternal-infant dyad. There is a critical need for more
research concerning the effect of breastfeeding on infants with NAS, particularly studies
that focus on the mother’s perception of the decision to breastfeed her infant. In addition,
intentional, multi-level interventions aimed at creating a more secure, compassionate, and
comfortable environment for the maternal-infant dyad will likely enhance outcomes for
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both mother and infant. Due to the significant increase in infants diagnosed with NAS,
those who care for these infants should utilize a standardized, objective, and validated
tool to guide the treatment of NAS. These strategies will ensure consistent, quality care
for this vulnerable maternal-infant dyad.
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Appendix A – PRISMA Diagram
PRISMA 2009 Flow Diagram
Key Terms: “Breastfeeding” and “Methadone”
Literature limitations: 2005 to 2019, humans, English language,
peer reviewed journals

Identification

A Scoping Review of the Benefits of Breastmilk for the
Methadone Dependent Maternal-Infant Dyad

EBSCOhost

PUBMED

SCOPUS

21

68

49

# of records screened
(n = 86)

# of records excluded
(n = 44)

# of full-text articles
assessed for eligibility
(n = 42)

# of full-text articles
excluded, with reasons
(n = 32)

# of studies included in
scoping review
(n = 10)

• Gray literature
• Reponses to editors
• Related to plasma
concentrations of
breastmilk
• Unrelated to maternal and
infant health benefits
• Related to clinical
management and
guidelines

Included

Eligibility

Screening

# of records after duplicates removed
(n = 86)
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Study Purpose

Study Design

39
Qualitative Focus
Group Design

Breastfeeding and
Methadone Therapy:
The Maternal
Experience

Maternal methadone
use in pregnancy:
factors associated
with the development
of neonatal
abstinence syndrome
and implications for
healthcare resources. Retrospective Cohort Univariate Analysis

Demirci, et al., 2015

Dryden, et al., 2009

semistructured interviews
and focus groups

Systematic Review

Bagley, et al., 2014

Assessment of NAS,
nonpharmacologic
interventions for NAS, and
pharmacologic treatment
for NAS.

Descriptive Statistics

Level of Evidence

Review of the
assessment and
management of
neonatal abstinence
syndrome

To assess the effects
of breast milk on the
severity and outcome
of neonatal
Retrospective Chart
Abdel-Latif et al., 2006 abstinence syndrome Review

Author, Date

Four hundred and fifty singleton
pregnancies of drug-misusing women
prescribed substitute methadone in
pregnancy.

Over half the infants
given appointments
for the outpatient
clinic defaulted on
two or more
occasions, reflective
of the complex
lifestyle of many drugmisusing parents.

Inner-city
maternity
hospital
providing
dedicated
multidisciplinary
care to drugmisusing
mothers

Case note review

Transcripts were analyzed and coded
using qualitative content analysis

Higher maternal
methadone dose is
associated with a
higher incidence of
NAS. Pregnant drugmisusing women
should be encouraged
and supported to
breastfeed. Their
infants are vulnerable
and draw heavily on
healthcare resources.

7 pregnant women and 4 postpartum
women enrolled in methadone
maintenance programs

Small sample
recruited from a single
geographic area,
which limits
generalizability of
findings. Women
were only
interviewed at a
single time point.

Interventions to
increase prevalence of
breastfeeding among
women taking
methadone should
address identified
logistical, educational,
and psychological
barriers and consider
inclusions of women
themselves, partners,
peers, and clinicians.

Inability to identify
nonopiate effects
(cocaine,
amphetamines, etc.)
as no tool is available
presently, as the
Finnegan scoring
system is only
validated for opiate
withdrawal.

Limitations

There is limited data
on the inter-observer
reliability of NAS
assessment tools due
to lack of a
standardized
approach.

Data Collection Methods

Results
Breast milk
significantly
ameliorates the
severity of NAS.
Infants who were fed
primarily breast milk
had significantly
reduced mean NAS
scores, delayed onset
of withdrawal, a
Finnegan's scoring tool : Assesses the decreased need for
CNS, GI, Respiratory, and selected
medication, and
autonomic symptoms (e.g. yawning,
shorter hospitalization
190 drug-dependent mother and infant sneezing, sweating). Tool consists of 30 that formula-fed
pairs.
items across 21 categories.
infants.
Nonpharmacologic
interventions,
particularly
breastfeeding, may
decrease NAS
severity. Opioid
medications, such as,
morphine or
methadone are
recommended first8 studies were included for NAS
line therapy, with
assessment, 13 studies were included
phenobarbital or
for nonpharmacologic interventions,
clonidine as secondand 7 studies were reviewed for
line adjunctive
pharmacologic management.
Literature Review
therapy.

Sample Description, Size

Treatment
center

Various
hospitals and
municipalities

Hospital in
Australia

Setting

Appendix B – Scoping Review Matrix

Appendix B – Scoping Review Matrix (Continued)
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Appendix B – Scoping Review Matrix (Continued)
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Manuscript 2
This paper is electronically published ahead of print in the Journal of Neonatal Nursing
(reprinted with permission). Adrian A. (2019). Factors influencing healthcare providers’
behaviors in the care of infants with neonatal abstinence syndrome (NAS): An integrative
review. DOI: https://doi.org/10.1016/j.jnn.2019.07.006
Factors Influencing Healthcare Providers’ Behaviors in the Care of Infants with Neonatal
Abstinence Syndrome (NAS): An Integrative Review
Abstract
Due to a significant increase in the number of infants diagnosed with neonatal abstinence
syndrome and the lengthy hospitalization often required for their pharmacologic
treatment, a comprehensive understanding of the factors that influence healthcare
providers’ behaviors in implementing nonpharmacological interventions for infants with
neonatal abstinence syndrome is needed. The Whittemore and Knafl methodology guided
an integrative review of literature on the current knowledge of the individual and
contextual factors that influence healthcare providers’ behaviors in implementing
nonpharmacological interventions that decrease the length of stay for infants with
neonatal abstinence syndrome through the lens of the Theoretical Domains Framework.
Results of this review may provide knowledge to inform future interventions and assist in
the development and implementation of best practice standards, clinical practice
guidelines, and protocols to improve the care of this vulnerable and rapidly-growing
patient population: the neonatal abstinence syndrome maternal-infant dyad.
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Neonatal abstinence syndrome; neonatal withdrawal; theoretical domains framework;
nonpharmacological interventions; nursing interventions; complementary therapy; length
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Appendix B – Literature Review Matrix
Author, Date

Asti et al, 2015

Casper et al, 2014

Grossman et al, 2017

Study Purpose

Study Design

A multidisciplinary
NAS task force was
created to implement
a standardized
treatment protocol,
discuss the strengths
and weaknesses of
the current medical
and nursing
management, and
improve
communication
Quality Improvement
among staff.
Project

A thorough review
and analysis of the
literature and
interviews with
neonatal experts
guided the
development of a
nursing CGP for
infants with NAS in a
level IV NICU.

Setting

Sample Description, Size

Nationwide
Children's
Hospital in
Columbus, Ohio 92 infants

A Level IV NICU
at Cincinnati
Children's
Quality Improvement Hospital Medical
Project
Center, Ohio

56-bed level IV NICU, employing more
than 170 RNs with staff experience
ranging from new graduate to over 30
years.

An initiative to
improve the quality of
Yale New Haven
care of infants with
Quality Improvement Children's
NAS
Project
Hospital
287 Infants

To evaluate the
effectiveness of a CPG
on increasing
identification of
neonates with NAS
symptoms based on a
toxicology screening
protocol, decreasing A Retrospective
Murphy-Oikonen et al, the mean NAS score Cohort Comparison
2012
and average LOS.
Design

Data Collection Methods

Neonatal medical record data

Results
Reliable monitoring of
symptoms and the
administration of a
standardized
morphine protocol
effectively reduced
LOS from 36 days to 18
days. One of the most
effective
interventions that
impacted the LOS was
the development of a
staff NAS education
program.

CPGs provide nurses
with clear direction
when caring for their
patients. The
guidelines are
designed to reduce
The CPG-update initiative included an the withdrawal
evaluation of the literature regarding syptoms and
nurse-driven interventions to support a discomfort of the
practice change that promotes
fragile newborn and
evidence-based care practices for
to nurture the
infants with NAS.
maternal-infant dyad.

Interventions focused
on nonpharmacologic
therapies and a
simplified approach to
assessment for infants
exposed to
methadone in utero
led to both substantial
and sustained
decreased in ALOS,
the proportion of
infants treated with
The outcome measures included ALOS, morphine, and
morphine use, and hospital costs using hospital costs with no
statistical process control charts.
adverse events.

There was a significant
decrease in the
overall average NAS
score and in the
number of measures
taken over time
between the two
groups. Similarly, the
A final sample of 90 neonates
change in CPG led to a
Regional
demonstrating NAS symptoms were
reduction in the LOS
hospital in a mid- included in this study; 20 in the preamong postsize Canadian
intervention group, and 70 in the post- Retrospective cohort comparison using intervention
city
intervention group
hospital record data for neonates
neonates.
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Appendix B – Literature Review Matrix (continued)
Author, Date

Study Purpose

Study Design

Nelson, 2016

The purpose of the
focused ethnography
was to desribe the
culture of care and
nonpharmacologic
nursing interventions
performed by NICU
nurses for infants with A focused
NAS.
ethnography

Patrick et al, 2016

Patrick et al (2016)
designed and
implemented a
multicenter quality
improvement
collaborative for
infants with NAS. The
objective was to
determine if the
collaborative was
effective in
standardizing hospital
policies and improving Quality Improvement
patient outcomes.
Project

Saunders et al, 2014

An evidence-based,
multidisciplinary NAS
protocol was
developed using a
stepwise continuous
quality improvement
(CQI) approach with
the goal of
standardizing care
procedures for these Quality Improvement
infants.
Project

Setting

Sample Description, Size

Data Collection Methods

Results
Results described the
culture of care
provided to infants
with NAS by NICU
nurses as evidenced
by six themes: learn
the baby, core team
relationships, role
satisfaction, grief,
making a difference,
and education and
care of the mother.

A 44-bed NICU at
a children's
hospital in the
southeastern US 12 full-time nurses

Observation and interviewing

199 participating
centers in the
multicenter,
multistate
quality
improvement
collaborative
3,458 infants

Of the participating
centers, the mean
number of NASfocused guidelines
increased from 3.7 to
5.1, with
Audit data were collected by each
improvements in all
center and reported to VON through
domains. Also, LOT
the use of an online data portal.
decreased from 16 to
Hospital standardization was measured 15 days and LOS
through serial assessment of hospital decreased from 21 to
policies.
19 days.

East Tennessee
Children's
Hospital is a 152bed hospital
dedicated to the
care of children
with a 60 bed
level III NICU
that admits 600700 patients
annually
413 Infants

The weaning time
from opioids
remained stable
throughout each CQI
steps. The overall
total NICU LOS was
reduced by 10.35 days,
and the the LOS after
Retrospective data analysis with
completing wean from
outcome variables of total LOS days,
opioids was reduced
number of days required to wean from by 2.79 days. Use of
opioids, and number of hospital days
adjunct medications
from opioid wean to discharge, and
decreased from 30.1%
number of adjunct medications.
to 24.5%.

53

Manuscript 3
A Mixed Methods Study to Investigate Barriers and Enablers to Nurses’ Implementation
of Nonpharmacological Interventions for Infants with Neonatal Abstinence Syndrome
(NAS)
Abstract
Background: The incidence of Neonatal Abstinence Syndrome has increased
significantly as a result of the opioid epidemic. A lengthy hospitalization is often required
to treat the infant’s withdrawal symptoms. A comprehensive understanding of factors that
influence nurses’ implementation of nonpharmacological interventions for infants with
Neonatal Abstinence Syndrome is needed.
Purpose: To investigate barriers and enablers to nurses’ implementation of
nonpharmacological interventions for infants with Neonatal Abstinence Syndrome
through the lens of the Theoretical Domains Framework.
Methods: A parallel convergent mixed methods study was conducted. Qualitative data
were collected using semi-structured interviews and quantitative data were collected
using a tailored Determinants of Implementation Behavior Questionnaire with neonatal
nurses. Findings from the interviews and surveys were merged through joint review to
compare and contrast themes.
Results: Enablers and barriers to nurses’ implementation of nonpharmacological
interventions included education, experience, ability to implement nonpharmacological
interventions, parental participation, stigmatization, lack of managerial/organizational
support, staffing ratios, internal and external resources, and stress. Knowledge, Skills,
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Beliefs about Capabilities, Social/Professional Role and Identity, Organization, and
Emotion of the Theoretical Domains Framework aligned with these themes.
Implications for Practice: Findings from this study will inform the development of
programs to improve nurses’ implementation of nonpharmacological interventions and
health and utilization outcomes in infants with Neonatal Abstinence Syndrome.
Implications for Research: Future work should focus on the development of programs
to improve nurses’ implementation of nonpharmacological interventions, with specific
strategies aimed to mitigate marginalization of vulnerable patient populations.
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Keywords
Neonatal Abstinence Syndrome; neonatal withdrawal; Theoretical Domains Framework;
nonpharmacological interventions; nursing interventions; length of stay
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Background
Up to 90% of neonates with in-utero opioid exposure experience Neonatal Abstinence
Syndrome (NAS),1 which results in deleterious symptoms and complications, prolonged
hospitalization, and extensive pharmacological therapy.2 In the United States, NAS
incidence increased 383% from 2000 to 2012.3 In 2012, infants with NAS were
hospitalized an average of 16.9 days (vs. 2.1 days for healthy newborns), costing an
estimated $1.5 billion; the majority of charges (81%) were paid by state Medicaid
programs, reflecting the greater tendency of opiate-dependent mothers to be from lower
income communities.4 Opiates (oral morphine, methadone) should be first-line
pharmacological treatment for infants with NAS2; however, nonpharmacological nursing
care is as critical as pharmacologic treatment in decreasing withdrawal symptoms. To
date, no research has focused on the barriers and enablers to nurses’ implementation of
nonpharmacological nursing interventions for this population.
Nonpharmacologic nursing interventions, refinement of nurses’ NAS assessment
skills, and accurate scoring of NAS withdrawal symptoms significantly reduces the
severity of withdrawal, length of treatment (LOT), and length of stay (LOS), and
improves maternal and infant outcomes.5 In contrast, ineffective nursing interventions,
inaccurate assessments, and insufficient utilization of abstinence scoring tools contribute
to unnecessary pharmacologic treatment, which prolongs drug exposure and
hospitalization to the possible detriment of maternal-infant bonding.6
Because nonpharmacologic nursing care is not complicated by the potentially harmful
side effects of pharmacological treatment, it should be the standard of care for opioid57

exposed infants.7 Examples of nonpharmacologic nursing interventions include
swaddling, providing quiet and low-stimulation environments, rooming-in, skin-to-skin
holding, breastfeeding (unless contraindicated), and infant positioning.8 Mitigating the
clinical complications of NAS may improve withdrawal severity, LOT, LOS, cost
associated with LOS, and behavioral outcomes including maternal attachment.9 The
purpose of this parallel convergent mixed methods study was to investigate barriers and
enablers to nurses’ implementation of nonpharmacological interventions for infants with
NAS through the lens of the Theoretical Domains Framework (TDF).
Theoretical Framework
The TDF provides a means to examine factors that influence healthcare providers’
behavior related to the implementation of evidence-based practice and interventions in
clinical practice.10 The TDF succinctly synthesizes various behavior change theories (33
theories and 128 primary theoretical constructs) into one framework for multidisciplinary
use.10 The TDF consists of 14 domains of theoretical constructs: ‘Knowledge,’ ‘Skills,’
‘Social/Professional Role and Identity,’ ‘Beliefs about Capabilities,’ ‘Optimism,’ ‘Beliefs
about Consequences,’ ‘Reinforcement,’ ‘Intentions,’ ‘Goals,’ ‘Memory, Attention, and
Decision Processes,’ ‘Environmental Context and Resources,’ ‘Social Influences,’
‘Emotion,’ and ‘Behavioral Regulation’.10
Methods
This convergent parallel mixed methods study was conducted through the lens of the
TDF. Quantitative data were collected using a Determinants of Implementation Behavior
Questionnaire for Neonatal Abstinence Syndrome (DIBQ-NAS) that assessed nurses’
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perceptions of barriers and enablers to implementation of nonpharmacological
interventions for infants with NAS. Qualitative semi-structured interviews and thematic
analysis were conducted to describe nurses’ perceptions of barriers and enablers to
implementation of nonpharmacologic nursing interventions. Merging of the interview and
DIBQ-NAS results allowed for identification and prioritization of barriers and enablers.
Data collection began after approval from the Institutional Review Board and the
National Association of Neonatal Nurses (NANN) research committee.
Qualitative Arm
A descriptive qualitative approach11 was applied to explore nurses’ perceptions of
barriers and enablers to implementation of nonpharmacological interventions. Purposeful
sampling was used to recruit participants from a Level II Neonatal Intensive Care Unit
(NICU) at an academic medical center and by offering members of NANN who
completed the DIBQ-NAS survey the option to participate in the interview. Participants
who met the inclusion and exclusion criteria were enrolled in the study (Table 1).
Table 1. Qualitative Inclusion and Exclusion Criteria
Inclusion Criteria
Nurses must be licensed and registered to
practice in their state

Exclusion Criteria
Nurses whose primary NAS experience is
related to infants withdrawing from
opioids/sedatives because the infant is on
mechanical ventilation. The type of NAS
experience was evaluated by the PI during
the participant screening process.

For participants recruited from the Level II
NICU, nurses must have at least 6 months’
experience caring for infants with NAS.
Semi-structured interviews were conducted using a guide with 8 open-ended
questions, followed by a demographic survey. The interview explored nurses’ perceptions
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and experiences with caring for infants with NAS; factors that impact the infants’ LOS;
efficacy of withdrawal scoring instruments; and mothers’ responses and interactions with
her infant. Interviews were conducted in person, in a private conference room, or via
phone according to the participants’ preference, audio recorded, and transcribed.
Theoretical saturation, the point at which no new information emerges in the data,12 was
met with fifteen participants.
Interviews were analyzed using conventional content analysis13 to code data into
common themes. The TDF was used as an initial coding framework, and the constantcomparative method was applied throughout the process until theoretical saturation was
met.
Demographic data were entered into REDCap14 and exported to SPSSv2515 for
analyses. Descriptive statistics, including frequency distributions, measures of central
tendency, and measures of dispersion or variation were computed on the demographic
characteristics (gender, age, race/ethnicity, and level of education and nursing
experience) of participants as appropriate.
Quantitative Arm
A tailored DIBQ-NAS was administered to assess nurses’ perceptions of barriers and
enablers to implementation of nonpharmacological interventions. Target sample size was
367 participants based on a 95% confidence interval, a ±5% margin of error and an
assumed standard deviation of 0.5.16 A link to the demographic survey and DIBQ-NAS,
administered through REDCap14 via email, was sent to the membership of NANN
(approximately 8200 members). A survey introduction and DIBQ-NAS link were posted
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to MyNANN Community. Three additional reminders were posted every two weeks. The
screening questionnaire reduced the study population to those meeting the inclusion
criteria (Table 2).
Table 2. Quantitative Inclusion and Exclusion Criteria
Inclusion Criteria
Nurses must be members of NANN, selfreport having at least 6 months’
experience caring for infants with NAS and
have access to a computer with a valid
email address.

Exclusion Criteria
None

The DIBQ was developed to measure behavior determinants of the 12-domain version
of the TDF.17 The initial DIBQ contained 100 items assessing the 12 TDF domains.
Results obtained from confirmatory factor analysis and Cronbach’s alpha resulted in the
DIBQ consisting of 93 items assessing an expanded 18 TDF domains, explaining 63.3%
of the variance, and internal consistency reliability values ranged from .68 to .93.
The DIBQ was designed to be easily adaptable for use in studies investigating
implementation behaviors of healthcare providers in various settings.18 Therefore, a
tailored, more succinct version of the DIBQ was developed for this study, the DIBQNAS (Appendix A). Tailoring was informed by findings from an integrative review5; the
DIBQ-NAS consists of 11 items to assess nurses’ perceptions of Knowledge, Skills,
Social/Professional Role and Identity, Beliefs about Capabilities, Environmental Context
and Resources, Organization, and Emotion in caring for infants with NAS and their
families. The DIBQ-NAS utilizes a Likert scale for responses, with lower values
representing less confidence/agreement and higher values representing greater
confidence/agreement. Data from the DIBQ-NAS and demographic surveys were stored
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in REDCap14 and exported to SPSSv2515 for analyses. Descriptive statistics, including
frequency distributions, measures of central tendency, and measures of variation were
computed as appropriate.
Merged Analysis
Results from the interviews and DIBQ-NAS were merged through joint display to
compare and contrast findings according to TDF domains (Table 3). A frequency analysis
was conducted by counting the number of interview participants who contributed to each
theme to establish priority barriers and enablers. All themes in which 50% (n = 7) or
more participants contributed data were considered priority. In addition, themes not
meeting the frequency benchmark but considered highly relevant to the study purpose
were also considered priority.
Table 3. Qualitative and Quantitative Joint Display
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TDF Domains

Qualitative Themes

Knowledge

Nurse Education

Skills

Nurse Experience

Beliefs about Capabilities

Nurses' Implementation of Interventions

Social/Professional Role
and Identity

Parental Participation
Lack of Parental Participation
Stigmatization

Organization

Lack of Managerial/Organization Support
Staffing Ratios
Internal and External Resources

Emotion

Stress (S)

Illustrative Quotes

DIBQ-NAS Responses

• " I think there needs to be more
information for consistency of care all
around. I think when you don't have
primarily the same two, or three, or four
nurses taking care of the patient, often the
care can vary, and I think the way that we
rate our NAS (infants) is still very subjective.
I think there's still a lot of lack of education
in how we rate it."
• “I think the longer you're taking care of
the children, the easier it gets, and you can
feel confident in caring for them and being
able to calm them down."
• "I think the nurses are really important.
They provide the soothing mechanisms to be
able to hold the babies and score the babies.
I feel like we're pretty competent. We're
trained, we get that competency, so what
we score them is going to impact whether
their morphine is weaned or not, and then
ultimately, their length of stay."
• "The infants whose parents are committed
and are there every day and staying for
significant lengths of time, bonding with the
baby, holding the baby; they typically have
much lower scores and are able to wean
faster and get discharged sooner."
• “I think because the parents can't be there
24/7 because they usually have other kids at
home so it's hard, your baby changes every
day and it's hard for them to really get to
know them, so I do feel like it's hard for
them to bond.”
• “I can see that being a perception of the
moms, and them not wanting to be in the
nursery, because they're afraid of what
people are thinking about them."

• I know how to deliver nonpharmacological
interventions, 83.9% strongly agreed, 12.5% agreed,
and 3.6% strongly disagreed.
• I have been trained in delivering
nonpharmacological interventions, 57.1% strongly
agreed, 32.1% agreed, 7.1% were neutral, and 3.6%
strongly disagreed.
• The organization I work in provides nursing staff
with training in implementing nonpharmacological
interventions, 26.8% strongly agreed, 32.1% agreed,
26.8% were neutral, 12.5% disagreed, and 1.8%
strongly disagreed.
• For me, performing an accurate withdrawal
assessment is..., 25% considered is very easy, 53.6%
considered it easy, 10.7% were neutral, and 10.7%
found it difficult.
• I have the skills to deliver nonpharmacological
interventions, 75% strongly agreed, 21.4% agreed,
and 3.6% strongly disagreed.

• "I would say the hospital approving more
nurses to take care of these babies and
understanding that sometimes they can be a
one on one if they have to be, and
supporting that, I would say that's currently
not there. So as far as I'm concerned, there
really isn't a lot of hospital support at this
time."
• “I think patient ratio is probably the
biggest challenge, finding enough time to
work with the patient to give them the
needed time to give the appropriate care.”
• “volunteers' ability to be there with the
baby that's withdrawing, give them that
comfort, I think would probably be the most
valuable asset and resource that we can
provide an NAS baby.”

Not assessed

• I can count on support from management of the
organization I work in when it becomes challenging to
care for infants with NAS, 33.9% strongly agreed,
35.7% agreed, 17.9% were neutral, 10.7% disagreed,
and 1.8% strongly disagreed.
• The management of the organization I work in is
helpful with delivering care and implementing
nonpharmacological interventions, 30.4% strongly
agreed, 35.7% agreed, 25% were neutral, 7.1%
disagreed, and 1.8% strongly disagreed.
• In the organization I work, all necessary resources
are available to deliver nonpharmacological
interventions, 35.7% strongly agreed, 33.9% agreed,
14.3% were neutral, 14.3% disagreed, and 1.8%
strongly disagreed.
• I can count on support from other nurses with whom
I work when it becomes challenging to provide care,
55.4% strongly agreed, 33.9% agreed, and 5.4% were
neutral.
• The organization I work in provides assistance to
nurses delivering care (for example, volunteers to
hold infants), 30.4% strongly agreed, 48.2% agreed,
7.1% were neutral, 12.5% disagreed, and 1.8%
strongly disagreed.
• "You want to make them (infants with
• The management of the organization I work in is
NAS) feel better. You want to care for them willing to listen to my problems with delivering care
appropriately, but when you feel like you're to infants with NAS, 39.3% strongly agreed, 35.7%
exhausting all efforts to give them what they agreed, 17.9% were neutral, 5.4% disagreed, and
need, but it's not what they need, or it's not 1.8% strongly disagreed.
enough, and they're still just utterly
miserable."
•"I think day in and day out, if it's a really
difficult situation, it can definitely be
stressful and fatiguing. Eventually at some
point they're (nurses) going to need a
break."
• "It wears you down sometimes to take
care of these patients because you can't give
them what they need, and so it is a little
fatiguing to take care of them, especially if
you have another patient or two that are
taking up a lot of your time."
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Results
Fifteen nurses (10 Level II NICU employees, 5 NANN members) participated in
interviews (Table 4). Sixty-three nurses responded to the DIBQ-NAS; 5 did not provide
responses beyond the screening questions and 2 did not meet the inclusion criteria. The
final sample was 56 participants (Table 4).
Results of the frequency analysis led to five TDF domains meeting priority status:
Knowledge, Skills, Beliefs about Capabilities, Social/Professional Role and Identity, and
Emotion. The domain Organization did not meet the priority benchmark but was
considered highly relevant and was included.
Table 4. Interview and DIBQ-NAS Demographic Statistics

Gender (Female)
Prefer Not to Provide
Age in Years
Mean ± SD (Median)
Race/Ethnicity
Asian
Hispanic or Latino
White
Asian and White
Hispanic or Latino and White
Prefer Not to Provide
Highest Degree Obtained
Associates Degree
Bachelor’s Degree
Master’s degree
Doctoral Degree
Prefer Not to Provide
Years Working as a Nurse
1-3 years
4-6 years
7 years or more
Prefer Not to Provide

Interview Participants
(n = 15)
93.3% (14/15)
0% (0/15)

DIBQ-NAS Participants
(n = 56)
96.4% (54/56)
1.8% (1/56)

37.1 ±12 (35)

48.3 ±10.9 (51)
3.6% (2/56)
1.8% (1/56)
84% (47/56)
3.6% (2/56)
1.8% (1/56)
5.4% (3/56)
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6.7% (1/15)
66.7% (10/15)
26.7% (4/15)
0% (0/15)
0% (0/15)

3.6% (2/56)
39.3% (22/56)
42.9% (24/56)
10.7% (6/56)
3.6% (2/56)

20% (3/15)
20% (3/15)
60% (9/15)
0% (0/15)

7.1% (4/56)
8.9% (5/56)
82.1% (46/56)
1.8% (1/56)

Years Providing Care for Infants with NAS
Less than one year
1-3 years
4-6 years
7 years or more
Prefer Not to Provide
Frequency of Providing Care for Infants with NAS
Less than once a week
About once a week
More than once a week
Unknown
Prefer Not to Provide
Care Setting
General Service Level 1 Newborn Nursery
General Service Level II Nursery
Separate/Designated NAS unit
Neonatal Intensive Care Unit (Level III or greater)
Prefer Not to Provide

0% (0/15)
20% (3/15)
26.7% (4/15)
53.3% (8/15)
0% (0/15)

1.8% (1/56)
10.7% (6/56)
10.7% (6/56)
75% (42/56)
1.8% (1/56)

13.3% (2/15)
73.3% (11/15)
6.7% (1/15)
6.7% (1/15)
0% (0/15)

26.8% (15/56)
41.1% (23/56)
26.8% (15/56)
3.6% (2/56)
1.8% (1/56)

0% (0/15)
73.3% (11/15)
0% (0/15)
26.7% (4/15)
0% (0/15)

1.8% (1/56)
19.6% (11/56)
7.1% (4/56)
69.6% (39/56)
1.8% (1/56)

Knowledge, Skills, and Beliefs about Capabilities
Most participants emphasized the importance of nurse education (n = 15), nurse
experience (n = 12), and nurses’ implementation of nonpharmacological interventions (n
= 10), which align with the TDF Knowledge, Skills, and Beliefs about Capabilities
domains.
Nurse Education. According to participants, nurse education is crucial to nurse selfefficacy, empathy, assessment skills, and knowledge of nonpharmacological and
pharmacological interventions and the NAS diagnosis. Participants suggested that
education may also mitigate potential biases towards mothers/families and their infants.
Nurses' knowledge of the maternal, birth, and infant histories also highly impact nursing
care. More education ensures consistency and assessment accuracy among care providers
and across hospital units. In addition, participants suggested having educational materials
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more readily available and accessible, such as imbedded educational scoring tools in
charting software as an opportunity for real-time education to increase scoring accuracy.
According to DIBQ-NAS responses, over 90% of nurses believed they knew how to
deliver nonpharmacological interventions for infants with NAS; however, only about half
of nurses believed they received adequate training on implementing these interventions.
The quantitative results further emphasize, as the interviewed participants suggested, the
need for more education and training.
Nurse Experience. Participants posited that more experience caring for infants with
NAS, specifically assessing and scoring the severity of withdrawal, leads to greater
assessment accuracy and overall nurse self-efficacy. According to DIBQ-NAS responses,
over 75% of nurses believed performing accurate withdrawal assessments to be easy.
Over half of those interviewed and 75% of nurses who completed the DIBQ-NAS had
more than 7 years of experience caring for infants with NAS.
Nurses’ Implementation of Nonpharmacological Interventions. Participants stated
their ability to implement nonpharmacological interventions, including accurate and
consistent withdrawal assessments and scoring of withdrawal symptoms, is crucial in
determining pharmacological management, which can significantly alter the infant's LOS.
In addition, managing withdrawal symptoms and ensuring the infant is feeding well and
gaining weight are critical milestones in preparation for hospital discharge.
Nearly all nurses (96%) responded on the DIBQ-NAS that they believed they had the
skills to deliver nonpharmacological interventions for infants with NAS. In addition to
consistency of care, several participants (n = 9) discussed the importance of “continuity
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of care” for the NAS parental-infant dyad. Participants indicated that the same nurse
(when possible) caring for the infant was instrumental in reducing withdrawal symptoms
and LOS and provided more accurate withdrawal assessments. According to participants,
“continuity of care” naturally facilitates the nurse-parent relationship bond. Further,
communication among nurses on an infant’s likes/dislikes of nonpharmacological
interventions aids in the delivery of optimal care.
Social/Professional Role and Identity
All participants discussed the importance of creating a welcoming environment to
encourage parental participation (n = 15) in infant care by including them as an integral
part of the care team. Several participants (n = 9) conveyed their concern regarding the
lack of parental participation, and how parental uninvolvement creates barriers in the
care. Numerous participants shared their views regarding how stigmatization (n = 8) and
the perception of stigma (by parents) (n = 9) of infants with NAS and their families
creates multiple barriers related to parental-infant and nurse-parent relationships. These
themes align with the TDF ‘Social/Professional Role and Identity’ domain.
Parental Participation. According to participants, the nurses’ role is to create a
welcoming environment and include parents as an integral part of the care team. A few
participants (n = 4) posited that establishing roles, clear boundaries, and expectations can
facilitate the development of the nurse-parent relationship. Nurse-guided parental
education can improve both parental and infant outcomes. Participants noted that
parental participation can positively influence self-efficacy, the parental-infant bond, and
the relationship between the nurse and parent and may decrease parental guilt, and the
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infant’s withdrawal scores and LOS. In addition, parental participation lends to greater
understanding of the NAS condition and pharmacologic treatment. Further, nurses
appreciate when parents attempt to understand and care for their infant to prepare for
discharge home. This care includes providing soothing techniques similar to those
utilized in the hospital, which can make the infant's transition more comfortable.
Conversely, participants (n = 10) discussed the lack of parental participation or
understanding of the infant’s diagnosis and knowledge of appropriate
nonpharmacological interventions as barriers to parental education, the development of
the nurse-parent relationship, the parental-infant bond, and a source of nurse stress.
Several participants (n = 6) described external factors such as maternal substance abuse
treatment, distance from the hospital, having other children, and having jobs, which limit
the time the parent can visit and care for their hospitalized infant and impairs their ability
to bond effectively. In addition, separating the mother from her infant due to delivery
complications, the initiation of pharmacologic treatment for the infant with NAS,
visitation requirements of Children and Family Services, or other complex social issues
also present barriers to parental participation and bonding.
Stigmatization. Several participants (n = 8) acknowledged stigmatization of parents
such as, judgmental statements and rumors during shift report or excluding the parent in
infant care, which creates barriers to the development of a positive nurse-parent
relationship and adversely impacts the parent's desire to visit, self-efficacy, and bonding
with the infant. Participants discussed how even the perception of stigma (n = 9) and
internalized guilt felt by parents may negatively impact their desire to visit and self68

efficacy. Most participants, regardless of their internal thoughts and beliefs about this
opioid-exposed patient population, remain professional, provide the best care, and desire
to teach parents infant care.
Organization
All participants (n = 15) addressed concerns regarding the amount of “hands-on” time
infants with NAS require and the lack of managerial/organizational support (n = 6) as
evidenced by inadequate staffing ratios (n = 15). Due to inadequate staffing ratios,
participants expressed gratitude for and dependence on volunteers (external team
resource; n = 15), and fellow internal staff members and interdisciplinary team members
(internal team resource; n = 12) to fully support care standards for infants with NAS and
their families. These themes align with the ‘Organization’ domain of the TDF.
Lack of Managerial/Organizational Support. Several participants (n = 6) reported
management exhibiting a lack of understanding and knowledge of NAS and the time
required to care for patients and their families, which led management to question unit
staffing ratios. Participants posited that managerial support is needed to ensure
appropriate staffing ratios are maintained. Some participants also suggested more
managerial presence and support are needed during night/weekend shifts. However,
quantitative findings indicated most participants felt supported by management. DIBQNAS responses indicated nearly 70% of nurses believed they could count on support
from management when it became challenging to care for infants with NAS. Similarly,
more than 65% of nurses believed management was helpful with delivering care and
implementing nonpharmacological interventions.
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Staffing Ratios. Participants stated infants with NAS require more time to care for
than the average patient, which should be reflected in staffing ratios. Inadequate staffing
ratios limit time with the infant, increase nurse stress, and lead to more errors and
inaccurate withdrawal scores. However, DIBQ-NAS responses indicated nearly 70% of
nurses believed their organization had all necessary resources available to deliver
nonpharmacological interventions. These findings contradict the results from the
interviews, which indicated nurses felt “under-staffed” and without enough time to care
for infants with NAS properly.
Internal and External Resources. All participants emphasized the importance of
volunteers when caring for infants with NAS and their families. They believed that more
volunteers are needed, particularly during night and weekend shifts. Participants stated
that volunteers are invaluable resources who hold and comfort infants, which reduces
withdrawal symptoms and allows nurses to care for other patients. Further, most
participants (n = 12) conveyed the importance of “teamwork” and stated that
interdisciplinary team support (occupational therapy, physical therapy) can reduce the
infant’s LOS, and improve care and overall infant outcomes. Participants added that
incorporating a “family integrated model of care” allows parents to provide care without
depending on the nurse, which promotes flexibility in staffing ratios.
The findings from the DIBQ-NAS were consistent with interview results. Responses
on the DIBQ-NAS indicated nearly 90% of nurses believed they could count on support
from other nurses when it became challenging to provide care for infants with NAS.
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Further, over 75% of nurses believed their organization assists nurses delivering care to
infants with NAS.
Emotion
Nurse stress was one of the most common themes (n = 15). The sources of stress vary
widely, which creates challenges to providing proper support for nurses. The TDF
domain most closely aligned with stress is ‘Emotion’.
Stress. Several participants (n = 7) said they experience heartbreak and frustration
when thinking about the infant’s diagnosis, its impact on the infant's life, and the infant's
life once discharged from the hospital, all while trying to deliver the best care. The
infant’s uncertain plan for the future (which may include going home with a foster parent,
relative, etc.) impacts the nurses’ bond with the infant and leads to stress. The complex
social issues often exhibited in families and the amount of education nurses provide to the
family also increase nurse stress. Additionally, it can be frustrating and stressful for the
nurse who is unable to soothe and comfort an infant experiencing withdrawal.
Participants indicated caring for infants with NAS, particularly during consecutive shifts,
contributes to nurse stress and fatigue. Participants emphasized the importance of
knowing their limitations, relying on resources, and taking breaks.
According to DIBQ-NAS responses, 75% of nurses believed that management was
willing to listen to their problems with delivering care to infants with NAS. The merged
findings suggest that although nurses experience stress caring for infants with NAS and
their families, most nurses feel management is willing to listen to their concerns and
challenges.
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Discussion
The purpose of this study was to investigate barriers and enablers to nurses’
implementation of nonpharmacological interventions for infants with NAS through the
lens of the TDF. Knowledge, Skills, and Social/Professional Role and Identity are the
most influential TDF domains for providers’ implementation of nonpharmacological
interventions aimed at decreasing the LOS for infants with NAS.5 Other potentially
influential contextual and environmental TDF domains such as, Beliefs about
Capabilities, Environmental Context and Resources, Organization, and Emotion were
also explored in this study.
Knowledge was identified as a key influential TDF domain. Specific and ongoing
education related to the NAS continuum of care, from early detection and intervention for
mothers and infants at risk through post-discharge identification and utilization of
community support services, is crucial to improving overall outcomes.19 Further, greater
knowledge of the NAS diagnosis, treatment modalities, infant comfort measures, and
withdrawal assessment criteria enhances nurse self-efficacy,20-22 mitigates stigmatization
of the NAS parental-infant dyad,23 and enables nurses to effectively implement
nonpharmacological interventions.
Once a solid foundation of knowledge has been established, nurses can refine their
skill set by gaining more experience in implementing nonpharamcolgoical interventions.
Skill, another highly influential TDF domain, is established through caring for infants
with NAS more frequently, incorporating unit “NAS core teams” (a team of nurses
committed to caring for these infants every shift), and when possible, providing
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“continuity of care.” The synergistic combination of greater knowledge and refined skill
results in more accurate withdrawal assessments and consistency in care, which has been
shown to decrease infant withdrawal severity and LOS.24
Consistency of care was identified as a key enabler to the effective implementation of
nonpharmacological interventions. The utilization of a withdrawal protocol is an
evidence-based, recommended strategy to establish a consistent, standard of care for
infants with NAS.24-27 Important caveats to this strategy include incorporating nurses’
input in the infants’ plans of care and recognizing patient individuality. Nurses, due to the
considerable amount of time spent caring for the NAS parental-infant dyad, are well
positioned to advise the care team and advocate for their patients and families to ensure
the best overall outcomes.
Nurses are a crucial component in the delivery of care for infants with NAS; however,
most nurses believe that parental participation in care is far more significant, particularly
as it relates to parental self-efficacy, parental-infant bonding, and the reduction of infant
withdrawal severity and LOS.28 Therefore, by nurses embracing their unique role and
creating a welcoming environment that includes parents as an integral part of the care
team, a family integrated model of care can be established. This care model has been
successful in enhancing the parental-infant bond, limiting treatment with medications,
and reducing infant withdrawal severity and LOS.28
The successful implementation of a family integrated model of care requires unbiased
support from interdisciplinary care team members. Although stigmatization of patient
populations is of considerable concern to healthcare providers, it is representative of the
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more significant issue of societal marginalization of those with Opioid Use Disorder
(OUD). Stigmatization of those with OUD by healthcare providers is a significant barrier
to effective and optimal treatment for pregnant women.29 Further, when women with
OUD do access healthcare, they often receive misinformation, inaction, and judgmental
attitudes by healthcare providers.30 Findings from this study indicate stigmatization
results in barriers to parental participation in infant care, self-efficacy, development of the
nurse-parent relationship, and parental-infant bonding. Therefore, due to the significant
increase in patients with OUD, healthcare organizations should invest in training and
education programs to support providers’ delivery of unbiased healthcare to vulnerable
patient populations.
Organization was identified as an influential TDF domain, and organizational support
was a key enabler to nurses’ implementation of nonpharmacological interventions. While
most patient caregiving responsibilities fall to nurses, healthcare organizations are
obligated to ensure care team members are equipped with the necessary resources to
deliver optimal care to patients. Organizational support not only includes investing in
training and education for providers, but also maintaining adequate staffing ratios to
ensure more challenging patients receive optimal care. Further, the inclusion and training
of volunteers and nursing assistants in comforting infants with NAS was viewed as an
extremely valuable resource in this study. Healthcare organizations can support nursing
staff by acknowledging and understanding the complexities of NAS care, offering a
multidisciplinary caregiving team approach,24,28 and investing in all necessary resources
to assist those who deliver care.
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One of the more insidious barriers to nurses’ implementation of nonpharamcolgoical
interventions was stress. Sources of participants’ stress varied widely, which complicates
organizational efforts to mitigate nurse fatigue and its far-reaching effects.31 These
findings are congruent with other studies that found nurses providing NAS care
experienced intensified traumatic experiences,32 ethical and moral distress,33 and were at
risk for compassion fatigue and burnout.34 Smith-Miller and colleagues35 posited that
addressing job-related factors could reduce nurse fatigue, errors, attrition and employer
costs while improving patient outcomes and job satisfaction among nurses. However,
addressing and monitoring fatigue in healthcare organizations remains challenging due to
lack of evidence-based fatigue policies.31 Despite the lack of evidence-based fatigue
policies, healthcare organizations should create a culture of safety by collaborating with
nurse leaders to develop strategies to manage nurse fatigue.31
Limitations
The development of the DIBQ-NAS was informed by findings of an integrative
review5, in which the TDF domains Knowledge, Skills, and Social/Professional Role and
Identity were identified as having the greatest influence on providers’ implementation of
nonpharmacological interventions to decrease the LOS for infants with NAS. Results
from the qualitative analysis identified other areas related in the Social/Professional Role
and Identity domain, such as parental participation, lack of parental participation, and
stigmatization that should be included in an expanded version of the DIBQ-NAS. Despite
attempts to recruit the targeted 367 participants, only 56 nurses completed the DIBQNAS. The small sample limited the ability to conduct linear modeling and predictive
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statistical analyses. Also, volunteer sampling approaches were used in this exploratory
study, which could limit the generalizability of the findings.
Implications for Practice
Nurses consistently rate higher in honesty and ethics than all other professions,36
comprise the majority of healthcare providers,37 deliver the most frequent, direct care to
patients, and are poised to transform the model and delivery of care for infants with NAS
and their families. Nurses have a unique role in delivering care to vulnerable and
marginalized patient populations, such as the NAS parental-infant dyad, and therefore
require training and educational programs on OUD and associated sequelae. Findings
from this study will inform the development of programs to improve nurses’
implementation of nonpharmacological interventions and health and utilization outcomes
in infants with NAS.
Implications for Research
Future research should focus on the development of programs to improve nurses’
implementation of nonpharmacological interventions for infants with NAS, with specific
strategies aimed to mitigate marginalization of vulnerable patient populations. Further,
the DIBQ-NAS should be expanded to include questions related to key themes identified
through qualitative analysis such as parental participation, lack of parental participation,
and stigmatization, which aligned with the Social/Professional Role and Identity TDF
domain.
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Appendix A: DIBQ-NAS
Adapted from the DIBQ Final questionnaire
For the purpose of completing this survey, the definition of “nonpharmacological
intervention(s)” includes the following nursing activities:
• Withdrawal assessment of the infant with Neonatal Abstinence Syndrome (NAS)
• Provision of caregiving interventions; for example, swaddling, holding, breastfeeding
support when indicated, non-nutritive sucking, inclusion of the mother in the care of her
infant
• Utilization of a withdrawal scoring instrument
1. I know how to deliver nonpharmacological interventions for infants with NAS.
______Strongly Disagree _______Disagree _______Agree _______Strongly Agree
2. I have been trained in delivering nonpharmacological interventions for infants with
NAS.
______Strongly Disagree _______Disagree _______Agree _______Strongly Agree
3. I have the skills to deliver nonpharmacological interventions for infants with NAS.
______Strongly Disagree _______Disagree _______Agree _______Strongly Agree
4. In the organization I work, all necessary resources are available to deliver
nonpharmacological interventions to infants with NAS.
______Strongly Disagree _______Disagree _______Agree _______Strongly Agree
5. I can count on support from management of the organization I work in, when it
becomes challenging to provide care for infants with NAS.
______Strongly Disagree _______Disagree _______Agree _______Strongly Agree
6. The management of the organization I work in is willing to listen to my problems with
delivering care to infants with NAS.
______Strongly Disagree _______Disagree _______Agree _______Strongly Agree
7. The management of the organization I work in is helpful with delivering care and
implementing nonpharmacological interventions for infants with NAS.
______Strongly Disagree _______Disagree _______Agree _______Strongly Agree
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Appendix A: DIBQ-NAS (continued)
8. The organization I work in provides nursing staff with training in implementing
nonpharmacological interventions for infants with NAS.
______Strongly Disagree _______Disagree _______Agree _______Strongly Agree
9. For me, performing an accurate withdrawal assessment for infants with NAS is…
______Very difficult ________Difficult

_______Easy

_______Very easy

10. The organization I work in provides assistance to nurses in delivering care to infants
with NAS. (for example, volunteers who hold infants).
______Strongly Disagree _______Disagree _______Agree _______Strongly Agree
11. I can count on support from other nurses with whom I work when it becomes
challenging to provide care for infants with NAS.
______Strongly Disagree _______Disagree _______Agree _______Strongly Agree
If you are interested in participating in a telephone interview regarding nurses’
perceptions of barriers and enablers to implementation of nonpharmacological nursing
interventions for infants with NAS, please indicate your interest by checking next to the
‘Yes’ statement below.
__________Yes, I am interested in participating in a telephone interview.
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Supplemental Appendix 1: DIBQ-NAS Statistics Matrix
DIBQ-NAS NANN Survey Descriptive Statistics (n = 56)

I know how to deliver nonpharmacological
interventions for infants with NAS.
I have been trained in delivering
nonpharmacological interventions for infants
with NAS.
I have the skills to deliver
nonpharmacological interventions for infants
with NAS.
In the organization I work, all necessary
resources are available to deliver
nonpharmacological interventions to infants
with NAS.
I can count on support from management of
the organization I work in, when it becomes
challenging to provide care for infants with
NAS.
The Management of the organization I work
in is willing to listen to my problems with
delivering care for infants with NAS.
The management of the organization I work
in is helpful with delivering care and
implementing nonpharmacological
interventions for infants with NAS.
The organization I work in provides nursing
staff with training in implementing
nonpharmacological interventions for infants
with NAS.
I can count on support from other nurses
with whom I work when it becomes
challenging to provide care for infants with
NAS.
The organization I work in provides
assistance to nurses delivering care to infants
with NAS. (for example, volunteers to hold
infants)

Strongly Agree

Agree

Neutral

Disagree

Strongly Disagree

83.9% (47)

12.5% (7)

0% (0)

0% (0)

3.6% (2)

57.1% (32)

32.1% (18)

7.1% (4)

0% (0)

3.6% (2)

75% (42)

21.4% (12)

0% (0)

0% (0)

3.6% (2)

35.7% (20)

33.9% (19)

14.3% (8)

14.3% (8)

1.8% (1)

33.9% (19)

35.7% (20)

17.9% (10)

10.7 (6)

1.8% (1)

39.3% (22)

35.7% (20)

17.9% (10)

5.4% (3)

1.8% (1)

30.4% (17)

35.7% (20)

25% (14)

7.1% (4)

1.8% (1)

26.8% (15)

32.1% (18)

26.8% (15)

12.5% (7)

1.8% (1)

55.4% (31)

39.3% (22)

5.4% (3)

0% (0)

0% (0)

30.4% (17)

48.2% (27)

7.1% (4)

12.5% (7)

1.8% (1)

Very Easy

Easy

Neutral

Difficult

Very Difficult

For me, performing an accurate withdrawal
25% (14)
53.6% (30)
10.7% (6)
10.7% (6)
0% (0)
assessment for infants with NAS is…
For the purpose of completing the survey, the definition of "nonpharmacological intervention(s)" included the following nursing activities:
• Withdrawal assessment of the infant with NAS
• Provision of caregiving interventions; for example, swaddling, holding, breastfeeding support when indicated, non-nutritive sucking,
and the inclusion of the mother/parent in the care of the infant
• Utilization of a withdrawal scoring instrument
Abbreviation: NAS, Neonatal Abstinence Syndrome
*Percentages are listed and frequencies are in parentheses.
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Table Legend
Table 1: Qualitative Inclusion and Exclusion Criteria
Table 2: Quantitative Inclusion and Exclusion Criteria
Table 3: Qualitative and Quantitative Joint Display
Table 4: Interview and DIBQ-NAS Demographic Statistics
Supplemental Appendix 1: DIBQ-NAS Statistics Matrix
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Summary
Overview
This dissertation study is comprised of three manuscripts, each contributing to the
identification and examination of key barriers and enablers to healthcare providers’
implementation of nonpharmacological interventions in the care of infants with Neonatal
Abstinence Syndrome (NAS) and their families. The first manuscript is a scoping review
of the literature on the benefits of breastmilk for the methadone dependent maternalinfant dyad. The second manuscript is an integrative review which identified the factors
that influence healthcare providers’ behaviors in the care of infants with NAS. The third
and final manuscript explores barriers and enablers to nurses’ implementation of
nonpharmacological interventions for infants with NAS.
The scoping review, guided by the Social Ecological Model (SEM), served as the
foundation for the dissertation study. Research has shown that despite the American
Academy of Pediatrics’ recommendation for mothers in methadone treatment to
breastfeed, breastfeeding is initiated at significantly lower rates than in the general
population (1). Understanding this discrepancy and the factors associated with infant
feeding decisions is important because breastfeeding has been shown to be a key
nonpharmacologic intervention that decreases infant withdrawal severity and length of
stay (LOS) (2-8), while improving infant nutrition, and promoting maternal self-efficacy
and maternal-infant bonding (6, 9-11). The scoping review findings suggested that many
barriers prevent mothers in methadone treatment from breastfeeding, including:
inconsistent advice from healthcare providers; lack of clear guidelines; feeding problems
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(associated with NAS sequalae); lengthy hospital stays that prohibit maternal-infant
bonding; and issues such as low self-esteem, lack of knowledge, or feelings of maternal
guilt (6, 12, 13). Health care providers should be knowledgeable about current
breastfeeding guidelines for mothers in methadone treatment so they are better equipped
to offer nonjudgmental, supportive counsel regarding common breastfeeding challenges
and maternal concerns (14).
The integrative review, guided by the Whittemore and Knafl methodology (15),
was the keystone for this dissertation study. The keystone is a central component on
which all else depends. The Theoretical Domains Framework (TDF) served as the lens
through which the current knowledge of individual and contextual factors that influence
healthcare providers’ behaviors in implementing nonpharmacological interventions was
examined. The integrative review findings were critical to this dissertation study because
the most influential TDF domains relevant to implementation of nonpharmacological
interventions aimed at decreasing the LOS for infants with NAS were identified, which
included Knowledge, Skills, and Social/Professional Role and Identity.
The primary themes within the TDF domains included: knowledge of NAS and
American Academy of Pediatrics recommendations on NAS management, nursing
competence (assessment skills and effective utilization of a withdrawal scoring
instrument), development of interpersonal relationships with parents within professional
boundaries, establishment of role within a multidisciplinary team, and leadership in the
management and care of infants with NAS. In addition to the Knowledge, Skills, and
Social/Professional Role and Identity domains, other potentially influential contextual
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and environmental TDF domains such as, Beliefs about Capabilities, Environmental
Context and Resources, Organization, and Emotion were incorporated into the
dissertation study to ensure the inclusion of all potential barriers and enablers to nurses’
implementation of nonpharmacological nursing interventions.
The final manuscript presents findings from a convergent parallel mixed methods
study, conducted through the lens of the TDF, which identifies and prioritizes barriers
and enablers to nurses’ implementation of nonpharmacological interventions for infants
with NAS. Joint review of qualitative and quantitative data was conducted, and the most
influential enablers and barriers were as follows: nurse education, nurse experience,
nurses’ ability to implement nonpharmacological interventions, parental participation,
stigmatization, lack of managerial/organizational support, staffing ratios, internal and
external resources, and stress. The TDF domains Knowledge, Skills, Beliefs about
Capabilities, Social/Professional Role and Identity, Organization, and Emotion aligned
with these themes.
Importance of Theoretical Framework
The TDF, a theoretical framework comprised of behavior change theories,
provides a structure to examine factors that influence healthcare providers’ behavior
related to the implementation of evidence-based practice and interventions in clinical
practice (16). The TDF was instrumental in this dissertation work because it provided the
lens through which influential factors in healthcare providers’ behaviors were identified
during the integrative review and served as the initial coding framework to identify
specific themes in the dissertation study. The TDF was selected as the guiding theoretical
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framework for this dissertation study because the TDF was developed as a
multidisciplinary tool to aid in the identification of influential behavioral factors to
develop effective strategies when implementing evidence-based interventions.
Limitations and Lessons Learned
The development of the tailored survey instrument for the dissertation study, the
Determinants of Implementation Behavior Questionnaire for Neonatal Abstinence
Syndrome (DIBQ-NAS), was informed by findings of the integrative review, in which
the TDF domains Knowledge, Skills, and Social/Professional Role and Identity had the
greatest influence on providers’ implementation of nonpharmacological interventions.
However, results from the qualitative analysis indicated other themes in the
Social/Professional Role and Identity domain, such as parental participation, lack of
parental participation, and stigmatization should be included in an expanded version of
the DIBQ-NAS.
Further, application of the TDF in the integrative review was challenging because
not all domains are mutually exclusive. To mitigate this challenge in the dissertation
study, data from participant interviews were analyzed using conventional content analysis
(17) to code data into themes. The TDF was the initial coding framework and the
constant-comparative method of data analysis was used throughout the process until
theoretical saturation was met.
In addition, despite attempts to recruit the goal of 367 participants for the DIBQNAS, such as sending reminders and offering gift card drawings, only 56 nurses
completed the survey. The small sample size limited the ability to conduct linear
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modeling and predictive statistical analyses. Volunteer sampling was used in this
dissertation study, which may limit the generalizability of findings.
Research Trajectory
In response to recollection of a meaningful verse, “the dissertation is not my last
word, rather it’s my first word,” the immediate next step in this research trajectory will be
to craft and submit two additional manuscripts presenting the findings from this
dissertation study.
More distal next steps in the trajectory will include expansion of the DIBQ-NAS
to include questions related to key themes identified through qualitative analysis such as
parental participation, lack of parental participation, and stigmatization, which aligned
with the Social/Professional Role and Identity TDF domain. While these themes were
considered high priority according to the qualitative frequency analysis, there were no
correlating survey questions that addressed these key themes. In addition, the findings
from this study will inform the development of programs to improve nurses’
implementation of nonpharmacological interventions in the care of infants with NAS,
with specific strategies aimed to mitigate marginalization of vulnerable patient
populations.
Contribution to Nursing and Clinical Care
Although significant research has been dedicated to pharmacologic treatment for
infants with NAS, there are very few studies that provide empirical evidence to guide
specific nonpharmacological interventions aimed to decrease the LOS for infants with
NAS. Further, until this dissertation study, there were no studies that incorporated the
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TDF as a structure to guide the development of strategies that influence healthcare
providers’ behavior related to the implementation of evidence-based practice and
interventions in clinical practice.
Through a scoping review, the benefits of breastmilk for the opioid-dependent
maternal-infant dyad were identified, factors associated with breastfeeding initiation for
the opioid-dependent maternal-infant dyad as they correlated to the SEM were evaluated,
and the importance of treating the infant with NAS as part of the maternal-infant dyad
was established. Further, health outcomes for the NAS maternal-infant dyad can be
improved through interventions that create a more welcoming, nonjudgmental, and
comfortable environment.
Factors that influence healthcare providers’ behaviors in implementing
nonpharmacological interventions to decrease the LOS for infants with NAS were
identified through an integrative review. Key factors included implementing evidencebased protocols, providing specialized training programs for healthcare providers,
including parents as an integral part of the care team; utilizing validated withdrawal
scoring instruments; and incorporating interdisciplinary team members in the care of
infants with NAS to improve outcomes.
Finally, results from the dissertation study can be applied to develop programs to
improve nurses’ implementation of nonpharmacological interventions in the care of
infants with NAS and their families. The most influential enablers and barriers to nurses’
implementation of nonpharmacological interventions were education, experience, ability
to implement nonpharmacological interventions, parental participation, stigmatization,
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lack of managerial/organizational support, staffing ratios, internal and external resources,
and stress. These qualitative themes correlate to the TDF domains Knowledge, Skills,
Beliefs about Capabilities, Social/Professional Role and Identity, Organization, and
Emotion. Findings indicate key areas that programs should target to improve nurses’
implementation of nonpharmacological nursing interventions in the care of infants with
NAS and their families.
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APPENDIX F. – Demographic Survey for Manuscript 3
Appendix 1 – Demographic Survey for Neonatal Nurses

1. What is your gender?
___________________________________
2. What is your age?
___________________________________

3. What is your race?
___________________________________
4. Are you of Hispanic origin?
___________________________________
5. What is your highest degree obtained?
___________________________________
6. How long have you been working as a nurse (in years and months)?
___________________________________
7. How long have you been providing care for infants with Neonatal Abstinence Syndrome (NAS)?
__________________________________
8. How frequently do you provide care for infants with Neonatal Abstinence Syndrome (NAS)?
__________________________________
9. What is the care setting in which you provide care for infants with Neonatal Abstinence
Syndrome (NAS)? (i.e., are infants with NAS cared for in a separate unit or in a general service Level II
nursery?)
__________________________________

IRB Number: Pro00080105
Date Approved: 08/20/2018
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Appendix 2 – Interview Guide for Neonatal Nurses
Opening
Hello, Thank you for meeting with me today and consenting to discuss your professional
insight regarding the care provided for infants diagnosed with Neonatal Abstinence Syndrome
(NAS).
My name is Allison Adrian, and I am a doctoral student in the nursing research program at the
College of Nursing at the Medical University of South Carolina. This interview, a component of a
mixed methods study, will be audio recorded, transcribed, and analyzed.
Introduction
Your privacy and anonymity is of utmost importance; therefore, your identity will be kept
confidential. Discussing sensitive subject matter, such as the care of infants with NAS, can be
emotionally troubling; if at any point during the interview you feel unable to continue, please feel
free to stop the interview. We can continue and/or reschedule the interview at your
convenience. The interview will be audio recorded for transcription purposes and will last
approximately 45 minutes. The audio recording will be destroyed immediately after the
information has been transcribed and analyzed. The information gained from this interview will
provide insight and rich data regarding nurses’ perceptions of providing care for infants with
NAS.
Questions
1. Please describe your experience as a nurse caring for infants diagnosed with Neonatal
Abstinence Syndrome (NAS).
Prompts
a. What challenges/frustrations do you experience when providing care for infants with
NAS?
b. What resources/support do you have available when providing care for infants with
NAS?
c. What resources do you feel are needed when providing care for infants with NAS?
2. What factors do you believe impact the length of stay for infants with NAS?
a. What impact do you believe nursing care has on the length of stay for infants with
NAS?
b. What impact do you believe the NAS pharmacological protocol has on the length of
stay for infants with NAS?
c. What impact do you believe the neonatologists’ methodology has on the length of stay
for infants with NAS?
d. What impact do you believe parents have on the length of stay for infants with NAS?
e. What do you think would help reduce the length of stay for infants with NAS?
3. What are your perceptions regarding the modified Finnegan scoring tool (F-NAST) in
the care of infants with NAS?
Prompts
a. What education did you receive during orientation/training regarding the assessment
of infants with NAS and the utilization of the modified Finnegan scoring tool? How would
you modify, if at all, the education and/or how it is currently implemented?
b. How confident do you feel in your ability to accurately assess and score an infant with
NAS?
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APPENDIX G. – Interview Guide for Manuscript 3 (continued)
Appendix 2 – Interview Guide for Neonatal Nurses (continued)
c. How important do you believe education is in developing a nurses’ confidence in their ability
to accurately assess and score an infant with NAS?
4. Please describe the hospital’s role in supporting nursing care of infants with NAS?
Thank you very much for your responses to my questions so far – I would like to change
topics and discuss your thoughts regarding the relationship between the nurse and the
mother of the infant with NAS.
5. Please share your thoughts on the role the care provider-mother relationship plays in
the infant’s progress.
a. Do you feel that stigma exists between nurses and mothers of infants with NAS?
b. Have you ever witnessed a mother being stigmatized by a nurse? If so, please share
your experience.
6. Do you think the mother’s perception of stigma (whether it exists or not) has an impact
on the maternal-infant bond? (i.e., Do you feel it impacts the mother’s visiting time, care she
provides her infant, her self-confidence in caring for her infant?)
7. Generally speaking, what are your perceptions regarding the mother’s responses and
interactions with her infant with NAS?
a. Based upon your experience, do you feel mothers are able to bond with their infants?
Please discuss your perceptions of facilitators and/or barriers to the mother-infant
bonding process.
8. How important do you believe the following factors are in caring for infants with NAS;
a nurse’s personality, nursing experience, knowledge of condition, knowledge of
nursing interventions?
a. Were you taught (nonpharmacological) nursing interventions to calm and soothe
infants with NAS?
b. Do you think nurses experience more fatigue and distress when caring for infants with
NAS?
c. Do you feel the acuity ranking of infants with NAS (nurse workload) is accurate?
Closing
I greatly appreciate you sharing your perspective regarding this vulnerable mother-infant
dyad. Please share any other thoughts or suggestions you may have with regard to caring for
these infants or the questions that have been asked during this interview. If necessary, would it
be acceptable for me to contact you for clarifications during the transcription and analytical
phase of data collection? I will provide you with a brief summary of the findings and major
themes identified once data collection and data analysis has been completed. Thank you again
for your participation.

IRB Number: Pro00080105
Date Approved: 08/20/2018
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APPENDIX H. – DIBQ-NAS Questionnaire for Manuscript 3
Appendix 3 – DIBQ-NAS
Adapted from the DIBQ Final questionnaire
For the purpose of completing this survey, the definition of “nonpharmacological
intervention(s)” includes the following nursing activities:
• Withdrawal assessment of the infant with Neonatal Abstinence Syndrome (NAS)
• Provision of caregiving interventions; for example, swaddling, holding, breastfeeding support
when indicated, non-nutritive sucking, inclusion of the mother in the care of her infant
• Utilization of a withdrawal scoring instrument
1. I know how to deliver nonpharmacological nursing interventions for infants with NAS.
(Domain: Knowledge; Construct: Knowledge)
________Strongly Disagree ________Disagree ________Agree ________Strongly Agree
2. I have been trained in delivering nonpharmacological nursing interventions for infants with
NAS.
(Domain: Skills; Construct: Skills)
________Strongly Disagree ________Disagree ________Agree ________Strongly Agree
3. I have the skills to deliver nonpharmacological nursing interventions for infants with NAS.
(Domain: Skills; Construct: Skills)
________Strongly Disagree ________Disagree ________Agree ________Strongly Agree
4. In the organization I work, all necessary resources are available to deliver
nonpharmacological interventions to infants with NAS.
(Domain: Organization; Construct: Organizational resources and support)
________Strongly Disagree ________Disagree ________Agree ________Strongly Agree
5. I can count on support from management of the organization I work in, when it becomes
challenging to provide care for infants with NAS.
(Domain: Organization; Construct: Organizational resources and support)
________Strongly Disagree ________Disagree ________Agree ________Strongly Agree
6. The management of the organization I work in is willing to listen to my problems with
delivering care to infants with NAS.
(Domain: Organization; Construct: Organizational resources and support)
________Strongly Disagree ________Disagree ________Agree ________Strongly Agree
7. The management of the organization I work in is helpful with delivering care and
implementing nonpharmacological interventions for infants with NAS.
(Domain: Organization; Construct: Organizational resources and support)
________Strongly Disagree ________Disagree ________Agree ________Strongly Agree
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Appendix 3 – DIBQ-NAS (continued)
8. The organization I work in provides nursing staff with training in implementing
nonpharmacological interventions for infants with NAS.
(Domain: Innovation strategy; Construct: Innovation strategies)
________Strongly Disagree ________Disagree ________Agree ________Strongly Agree
9. For me, performing an accurate withdrawal assessment for infants with NAS is…
(Domain: Beliefs about capabilities; Construct: Perceive behavioral control)
________Very difficult
_________Difficult
________Easy ________Very easy
10. The organization I work in provides assistance to nurses in delivering care to infants with
NAS. (for example, volunteers who hold infants).
(Domain: Innovation strategy; Construct: Innovation strategies)
________Strongly Disagree ________Disagree ________Agree ________Strongly Agree
11. I can count on support from other nurses with whom I work when it becomes challenging to
provide care for infants with NAS.
(Domain: Social Influences; Construct: Social support)
________Strongly Disagree ________Disagree ________Agree ________Strongly Agree
If you are interested in participating in a telephone interview regarding nurses’ perceptions of
barriers and enablers to implementation of nonpharmacological nursing interventions for infants
with NAS, please indicate your interest by checking next to the ‘Yes’ statement below.
__________Yes, I am interested in participating in a telephone interview.

IRB Number: Pro00080105
Date Approved: 08/20/2018
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Appendix 4 - Information for Interview Participants document

Barriers and Enablers to Nurses’ Implementation of Nonpharmacological
Interventions for Infants with Neonatal Abstinence Syndrome (NAS).
You are being asked to participate in a research study. A study to investigate barriers
and enablers to nurses’ implementation of nonpharmacological interventions for infants with
Neonatal Abstinence Syndrome (NAS) will be conducted to inform the development of
educational programs for nurses aimed at facilitating the implementation of nonpharmacological
nursing interventions to improve the care of a vulnerable and rapidly-growing patient population:
the NAS maternal-infant dyad.
We will be recruiting nurses who are familiar with Neonatal Abstinence Syndrome (NAS)
and have at least 6 months of experience caring for infants diagnosed with NAS. Study
participants will be nurses recruited from the Level 2 Neonatal Nursery at the Medical University
of South Carolina (MUSC) and the National Association of Neonatal Nurses (NANN).
Study participants will be asked to complete a demographic survey and interview with
the principal investigator, which should take approximately 45 minutes. The interviews will be
conducted in a private conference room at the Children’s Hospital at MUSC, or via phone or
videoconference according to the participants’ preference. Study participants recruited from
NANN will be asked to complete a demographic survey administered through REDCap via
email.
Your confidential participation in this study is voluntary. Participants will receive no direct
benefit from the study. However, the information gained from this study will inform the
development of educational programs for nurses to improve the care of the NAS maternal-infant
dyad. If you are interested in being a part of this study, or if you would like more information,
please call or email Allison at (843) 819-8946 or adrian@musc.edu.

Thank you,
Allison Adrian, BSN, RN
Principal Investigator

IRB Number: Pro00080105
Date Approved: 08/20/2018
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1 of 1

Appendix 5 - Information for Survey Participants document

Barriers and Enablers to Nurses’ Implementation of Nonpharmacological
Interventions for Infants with Neonatal Abstinence Syndrome (NAS).
You are being asked to participate in a research study. A study to investigate barriers
and enablers to nurses’ implementation of nonpharmacological interventions for infants with
Neonatal Abstinence Syndrome (NAS) will be conducted to inform the development of
educational programs for nurses aimed at facilitating the implementation of nonpharmacological
nursing interventions to improve the care of a vulnerable and rapidly-growing patient population:
the NAS maternal-infant dyad.
We will be recruiting nurses who are familiar with Neonatal Abstinence Syndrome (NAS)
and have at least 6 months of experience caring for infants diagnosed with NAS. Study
participants will be recruited from the National Association of Neonatal Nurses (NANN) utilizing
the NANN Listservs resource. Study participants will be asked to complete a demographic
survey and a tailored Determinants of Implementation Behavior Questionnaire (DIBQ-NAS),
administered via REDCap through email, which should take approximately 10 minutes.
Your confidential participation in this study is voluntary. Participants will receive no direct
benefit from the study. However, the information gained from this study will inform the
development of educational programs for nurses to improve the care of the NAS maternal-infant
dyad. If you are interested in being a part of this study, or if you would like more information,
please call or email Allison at (843) 819-8946 or adrian@musc.edu.

Thank you,
Allison Adrian, BSN, RN
Principal Investigator

IRB Number: Pro00080105
Date Approved: 08/20/2018
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Barriers and Enablers to Nurses’ Implementation of Nonpharmacological
Interventions for Infants with Neonatal Abstinence Syndrome (NAS).
You are being asked to participate in a research study.
A study to investigate barriers and enablers to nurses’ implementation of
nonpharmacological interventions for infants with Neonatal Abstinence Syndrome (NAS) will
be conducted to inform the development of educational programs for nurses aimed at
facilitating the implementation of nonpharmacological nursing interventions to improve the
care of a vulnerable and rapidly-growing patient population: the NAS maternal-infant dyad.

●

We will be recruiting nurses who are familiar with Neonatal Abstinence Syndrome (NAS) and

have at least 6 months of experience caring for infants diagnosed with NAS. Study participants will
be nurses recruited from the Level 2 Neonatal Nursery at the Medical University of South Carolina
(MUSC) and the National Association of Neonatal Nurses (NANN).
●

Study participants will be asked to complete a demographic survey and interview with the

principal investigator, which should take approximately 45 minutes. The interviews will be conducted
in a private conference room at the Children’s Hospital at MUSC, or via phone or videoconference
according to the participants’ preference. Study participants recruited from NANN will be asked to
complete a demographic survey administered through REDCap via email.
●

Your confidential participation in this study is voluntary. Participants will receive no direct benefit

from the study. However, the information gained from this study will inform the development of
educational programs for nurses to improve the care of the NAS maternal-infant dyad.
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A. SPECIFIC AIMS
Specific Aims
Among neonates with in-utero exposure to opioids, an estimated 60-90% experience drug
withdrawal, a condition defined as Neonatal Abstinence Syndrome (NAS) (1). In the United States, the
incidence of NAS increased 383% from 2000 to 2012 (2). In 2012, infants with NAS stayed in the
hospital an average of 16.9 days (compared to 2.1 days for healthy newborns), costing hospitals an
estimated $1.5 billion; the majority of these charges (81%) were paid by state Medicaid programs,
reflecting the greater tendency of opiate-abusing mothers to be from lower income communities (3).
NAS often results in prolonged hospitalization and extensive pharmacological therapy and is
characterized by a wide array of deleterious symptoms and complications, including increased
irritability, hypertonia, tremors, feeding intolerance, emesis, watery stools, seizures, and respiratory
distress (4). Extensive research has been conducted on pharmacologic treatment for infants with NAS.
Specifically, researchers agree that opiates (oral morphine, methadone) should be first-line treatment
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(4). Although nonpharmacological nursing care may be as critical in decreasing withdrawal symptoms
in infants with NAS, to date no research has focused on the barriers and enablers to nurses’
implementation of nonpharmacological nursing interventions for this vulnerable patient population.
A preliminary integrative review of factors influencing healthcare providers’ behaviors in the care of
infants with NAS revealed that the inclusion of nonpharmacologic nursing interventions, refinement of
NAS assessment skills, and accurate scoring of NAS withdrawal symptoms significantly reduced the
severity of withdrawal, length of treatment (LOT), and length of stay (LOS), and improved maternal and
infant outcomes (5-7). In contrast, ineffective nursing interventions, inaccurate assessments, and
insufficient utilization of abstinence scoring tools contribute to unnecessary pharmacologic treatment,
which prolongs drug exposure and hospitalization to the possible detriment of maternal-infant bonding
(8).
Because nonpharmacologic nursing care is not complicated by potentially harmful side effects of
pharmacological treatment, it should be considered the standard of care for opioid-exposed infants (9).
Nonpharmacologic nursing care consists of the careful assessment of mother and infant, provision of
caregiving interventions, and the adaptability of environmental and social interactions that support
neurodevelopment and physiological stability (9). Mitigating the clinical complications of NAS may
improve outcomes such as withdrawal severity, LOT, and LOS, and those that are more challenging to
measure, including maternal attachment (10). Further, decreasing NAS infants’ LOS by 2 days could
result in nationwide savings of an estimated $170 million in hospital charges per year (11).
The purpose of this parallel convergent mixed methods study is to investigate barriers and
enablers to nurses’ implementation of nonpharmacological interventions for infants with NAS
through the lens of the Theoretical Domains Framework.
Aim #1: To explore nurses’ perceptions of barriers and enablers to implementation of
nonpharmacological nursing interventions for infants with NAS using a descriptive qualitative
approach.
a) Conduct semi-structured interviews with up to 20 experienced Neonatal Intensive Care Unit
(NICU) nurses who care for infants with NAS.
b) Perform directed content analysis of the interviews, using the TDF as a coding framework to
identify specific themes.
Aim #2: To measure nurses’ perceptions of barriers and enablers to implementation of
nonpharmacological nursing interventions for infants with NAS using a tailored Determinants of
Implementation Behavior Questionnaire (DIBQ-NAS).
a) Administer the DIBQ-NAS to members (n = 367) of the National Association of Neonatal Nurses
(NANN) utilizing the NANN Listservs resource.
Aim #3: To merge the interview and DIBQ-NAS results to identify and prioritize barriers and
enablers to inform future implementation of nonpharmacological nursing interventions for
infants with NAS.
Impact
The findings will inform the future development of educational programs for nurses aimed at
facilitating the implementation of nonpharmacological nursing interventions to improve the care of this
vulnerable and rapidly-growing patient population: the NAS maternal-infant dyad.
B. SIGNIFICANCE
B.1. The NAS burden to the healthcare system and individuals has reached epidemic
proportions.
This study addresses the gap in research on the barriers and enablers to nurses’ implementation of
nonpharmacological nursing interventions aimed at reducing NAS infants’ withdrawal severity and
decreasing infants’ LOT and LOS. From 2009 to 2012, NAS incidence increased nationally from 3.4 to
5.8 per 1000 hospital births, reaching a total of 21,732 infants with the diagnosis (3,11). During the
same time period, the aggregate hospital costs attributed to the care of infants with NAS increased from
$732 million to $1.5 billion (11). In addition, admissions of infants with NAS to NICUs increased from 7
to 27/1000 between 2004 and 2013, with an associated increase in the LOS from 13 to 19 days (12). If
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pharmacologic treatment was required, the LOS increased to an average of 23 days (11). Evidence has
shown that prolonged hospitalization separates the mother from her infant and impairs bonding, an
impairment associated with negative developmental and behavioral outcomes (13).
On a global level, this epidemic significantly impacts healthcare systems, as studies have shown inutero exposure to opioids is associated with intrauterine growth restriction, congenital anomalies,
prematurity, low birth weight, and NAS (14). In the US, the federal government promoted the 2015
Protecting Our Infants Act (S.799), with the objectives of improving NAS surveillance programs,
addressing research gaps, and implementing effective measures for education, prevention, and
treatment (15). The US Department of Health and Human Services determined that gaps in research
were related to “the most appropriate treatment and management of infants with NAS” (S.799). This
study is designed to inform the future development of educational programs for nurses focused on the
implementation of nonpharmacological nursing interventions. Developing educational programs for
nurses will aid in establishing a knowledge base that aligns with several objectives of the Protecting
Our Infants Act (S.799).
B.2. The implementation of standardized protocols for NAS management is associated with
decreased LOS and hospital costs (16,17).
The American Academy of Pediatrics (AAP) Committee on Drugs recommends the establishment of
an evidence-based protocol guiding the assessment and management of infants diagnosed with NAS
or those at high risk for withdrawal (8). Although current NAS screening, assessment, and treatment
methods have limitations, the AAP committee suggests all clinicians be educated on the utilization of
published withdrawal assessment tools (8). However, the assessment and care management of infants
with NAS varies widely among hospitals in the US, and existing protocols have been based on minimal
empirical data (18). In a recent survey of accredited US neonatology fellowship programs, only 55%
had implemented a written NAS management protocol, and only 69% used a published abstinence
scoring system to determine the severity of withdrawal and inform the treatment provided (19).
In addition, new research findings are often not disseminated to clinicians and therefore not
implemented into practice (20). As a result, infants may not receive the recommended course of
treatment and may instead receive unnecessary, ineffective, or even harmful therapies (20). This study
will identify barriers and enablers to nurses’ implementation of nonpharmacological nursing
interventions, such as NAS management protocols, which have been shown to reduce withdrawal
severity, LOT, LOS, and hospital costs while improving the care of this vulnerable and rapidly-growing
patient population (16,17).
B.3. Experts recommend treating the maternal-infant dyad as the standard of care as opposed
to treating the infant with NAS alone (21-23).
The nurse’s role is to properly assess and interpret the infant’s behaviors, determine how the mother
understands and responds to her infant, and tailor interventions that help the mother care for her infant
(9). However, even though they are well-positioned to have a positive influence on the maternal-infant
dyad, nurses often exhibit judgmental behaviors because of negative stereotypes about opioiddependent mothers (9). In addition, maternal feelings of fear, guilt, and shame related to drug use often
limit the mother’s ability to have honest conversations with nurses (24). Recent evidence indicates that
nurses often lack the required knowledge to provide optimal care to the maternal-infant dyad, a barrier
that may also limit the development of nurse-mother relationships (25). To address these problems,
research suggests nurses providing care for infants with NAS should receive specialized training that
addresses all facets of nursing care, including detailed information on adult addiction and drug use
during pregnancy, maternal attachment behaviors, encouragement of appropriate maternal behavior,
and breastfeeding when appropriate (24,26). This study is significant as the findings can inform the
future development of specialized educational programs for nurses focused on the implementation of
nonpharmacological nursing interventions, such as supporting breastfeeding when appropriate, caring
for the maternal-infant dyad, and promoting nurse-mother relationships, factors that have been shown
to improve outcomes for the maternal-infant dyad (9,26,27).
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C. INNOVATION
This mixed methods study is innovative because it is the first to investigate barriers and enablers to
nurses’ implementation of nonpharmacological interventions for infants with NAS. The utilization of a
mixed methods approach, that includes the administration of a tailored Determinants of Implementation
Behavior Questionnaire (DIBQ-NAS) to members of NANN, will allow the investigator to gain a
comprehensive perspective of the barriers and enablers to nurses’ implementation of
nonpharmacological interventions for infants with NAS. A second source of innovation is that this study
will be the first to utilize the Theoretical Domains Framework (TDF) to guide the exploration of certain
behavioral constructs of nurses’ implementation of nonpharmacological nursing interventions for infants
with NAS. The TDF provides a structure for assessing and evaluating the factors that affect the
behavior of healthcare providers and the implementation of evidence-based practice (28, 29).
The results of the interviews and DIBQ-NAS will be merged to identify and prioritize barriers and
enablers to nurses’ implementation of nonpharmacological interventions for infants with NAS.
Understanding these factors will aid in the development of specialized educational programs for nurses,
which will include all facets of nursing care for the NAS maternal-infant dyad to improve the care and
outcomes of this vulnerable and rapidly-growing patient population. This research is critical to
establishing a deeper, richer knowledge of the NAS maternal-infant dyad and the nurses who care for
this complex patient population.
D. GUIDING THEORETICAL FRAMEWORK
The developers of the TDF identified 33 theories and 128 key theoretical constructs associated
with behavior change and synthesized them into one framework that can be used to guide theoretical
assessment of implementation problems, as well as professional and other health-related behaviors as
a basis for intervention development (28). Knowledge, Skills, and Social/Professional Role and Identity
were previously identified as the most influential domains relevant to providers’ implementation of
nonpharmacological interventions aimed at decreasing the LOS for infants with NAS (30). The
Knowledge domain of the TDF includes the following constructs: knowledge, knowledge about
condition/scientific rationale, schemas + mindsets + illness representations, and procedural knowledge
(31). The Skills domain of the TDF includes the following constructs: skills, competence/ability/skill,
assessment, practice/skills development, interpersonal skills, and coping strategies (31). The
Social/Professional Role and Identity domain of the TDF includes the following constructs: identity,
professional identity/boundaries, role, group/social identity, social/group norms, and
alienation/organizational commitment (31). In the preliminary integrative review, the primary themes
identified within these domains included: knowledge of NAS and AAP recommendations regarding the
management of NAS, nursing competence (assessment skills and effective utilization of the Finnegan
scoring tool), development of interpersonal relationships with parents within professional boundaries,
establishment of role within a multidisciplinary team, and leadership in the management and care of
infants with NAS. In addition to the Knowledge, Skills, and Social/Professional Role and Identity
domains, this study will investigate other influential contextual and environmental domains related to
infants with NAS and the nurses that care for the NAS maternal-infant dyad.
E. DIVERSITY AND SOCIAL DETERMINANTS OF HEALTH
The intent of this study is to obtain a diverse sample of participants with regard to nurses’ gender,
age, race/ethnicity, level of education and nursing experience. The patient population being served by
this study, the maternal-infant dyad, has experienced changes over the past several years with regard
to race and ethnicity. A recent study showed an increasing proportion of mothers of white race (from
64% in 2004-2005 to 76% in 2012-2013) and a corresponding decrease during the study period in the
proportions of mothers of black race and Hispanic ethnic group (p<.001) (12). However, the study also
showed no significant changes in maternal age, gravidity, parity, or percentage of mothers who
received prenatal care from 2005-2005 to 2012-2013 (12). In addition, the pattern of opioid use has
shifted from an inner-city, low-income population to a more socioeconomically and demographically
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diverse population that includes pregnant women (32,33). Findings from recent research highlight the
critical need to understand the significant increase in healthcare utilization and clinical treatment of
infants with NAS in order to define research priorities and design public health programs to improve
healthcare delivery for the infants and their mothers (12). The findings from this study will inform future
development of specialized educational programs for nurses focused on caring for the maternal-infant
dyad and promoting nurse-mother relationships, factors that have been shown not only to enhance
maternal self-efficacy but also to address stigmatization, a Social Determinant of Health, of the NAS
maternal-infant dyad by healthcare providers (34). Further, specialized education for mothers of infants
with NAS provided by nurses is an additional Social Determinant of Health to be addressed in this
proposed study (34).
F. APPROACH
F.1. Preliminary Studies
The principal investigator (PI) is currently completing a small pilot study to explore how nurses and
other key interdisciplinary team members perceive the treatment plan and care provided for infants with
NAS. The findings from the pilot study will be used to inform and further refine the research design and
methods for this study. In preparation for this study, the PI completed an integrative review, guided by
the constructs of the TDF, which focused on factors influencing healthcare providers’ behaviors in the
care of infants with NAS. Knowledge, Skills, and Social/Professional Role and Identity were the most
influential domains relevant to modifying healthcare providers’ behaviors surrounding implementation of
nonpharmacological interventions aimed at decreasing the LOS for infants with NAS.
F.2. Design Overview
This convergent parallel mixed methods study will be conducted through the lens of the TDF. The
concurrent timing of quantitative and qualitative strands will allow the PI to equally prioritize each
method and utilize two independent forms of data, allowing for greater insight into the phenomena.
Quantitative data collection will involve participants’ completion of a DIBQ-NAS that measures nurses’
perceptions of barriers and enablers to implementation of nonpharmacological nursing interventions for
infants with NAS. In addition, descriptive data from quantitative and qualitative study participants will be
collected through brief demographic surveys. Semi-structured interviews will be conducted to provide
qualitative data for thematic analysis to describe nurses’ perceptions of barriers and enablers to
implementation of nonpharmacologic nursing interventions for infants with NAS. The merging of the
interview and DIBQ-NAS results will allow for the identification and prioritization of barriers and
enablers to inform future implementation of nonpharmacological nursing interventions for infants with
NAS.
F.3. Mixed-Methods Methodology
For the purposes of presenting the research design and methods, each one of the three
individual aims will be presented individually.
Aim #1: To explore nurses’ perceptions of barriers and enablers to implementation of
nonpharmacological nursing interventions for infants with NAS using a descriptive qualitative
approach.
Introduction: Semi-structured, individual interviews using open-ended questions will be conducted
to explore nurses’ perceptions of barriers and enablers to caring for infants with NAS. The PI will
request a waiver of signed consent from the Institutional Review Board (IRB) at MUSC. Prior to each
participant’s inclusion in the study, the PI will explain the full details of the interview procedures as well
as the risks involved. Participants will also be informed that they are free to withdraw from the study at
any time. Before protocol-specific procedures commence, the PI will explain the aspects of healthcare
provider privacy concerning research specific information. Each participant and consenting professional
will receive an information sheet regarding the study via email prior to the interview. At the beginning of
the interview, the PI will deliver detailed verbal instructions regarding the demographic survey and
interview. The PI will ask 8 open-ended questions with probes using an interview guide. Completion of
the demographic survey and interview will take approximately 45 minutes.
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F.4. Setting
Study participants will be recruited from the Level 2 Neonatal Nursery of the NICU at MUSC. The
NICU at MUSC currently employs over 200 nurses and is a state-designated regional perinatal center,
providing comprehensive care to healthy and critically ill newborns throughout the state. Each year
approximately 2,000 newborns are delivered at MUSC, and an additional 12,000 babies are born within
MUSC’s referral area. These deliveries generate approximately 900 admissions to the intensive care
nurseries. Neonatal transports from outside facilities account for 40% of the total admissions to MUSC’s
NICU.
F.5. Sample
Purposeful sampling will be used to recruit participants who have experience caring for infants with
NAS and their families. The intent will be to obtain a diverse sample of participants with regard to
gender, age, race/ethnicity, and level of education and nursing experience.
The PI will recruit up to 20 participants for interviews until theoretical saturation is achieved.
Theoretical saturation is the point at which no new information emerges in the data (35). The PI will
recruit nurses who have at least 6 months of experience caring for infants diagnosed with NAS (see
Table 1). The demographic surveys and interviews will be conducted in person, in a private conference
room located in the Children’s Hospital at MUSC, or via phone or videoconference according to
participants’ preference. Interview participants will be recruited from the Level 2 Neonatal Nursery of
the NICU and members of NANN who have completed the DIBQ-NAS and selected the option to
participate in an interview.
Table 1 – Inclusion and Exclusion Criteria
Inclusion Criteria
• Nurses must be licensed and registered to
practice in their state.

Exclusion Criteria
• Nurses whose primary NAS experience is
related to infants withdrawing from
opioids/sedatives because the infant is on
mechanical ventilation. The type of NAS
experience will be evaluated by the PI during the
participant screening process.

• For participants recruited from the Level 2
Neonatal Nursery of the NICU at MUSC, nurses
must have at least 6 months’ experience caring
for infants with NAS.
F.6. Eligibility and Recruitment
Nurses who have at least 6 months’ experience caring for infants diagnosed with NAS will be invited
to participate in this study. For Level 2 Neonatal Nursery nurses, invitations to participate will be
extended via employee group emails, flyers located in staff areas, and monthly staff meetings. After a
nurse has expressed interest in participating by emailing or calling the PI, the PI will contact the
potential participant, briefly describe the study, and screen for eligibility. Once the nurse is determined
to be eligible, the PI will proceed with enrollment in the study. Additional interview participants will be
recruited to complete the DIBQ-NAS. Members of NANN will indicate their willingness to participate in a
phone or videoconference interview with the PI by selecting an option at the end of the questionnaire.
The PI will be notified via REDCap of a participant’s interest in completing an interview. The PI will
contact the interested member via email or phone to complete the eligibility screening process.
Pending study funding, interview participants will be entered into a drawing to receive 1 of 2 $25 gift
cards.
F.7. Data Collection

120

APPENDIX M. – Protocol for Manuscript 3 (continued)
Demographic information on gender, age, race/ethnicity, and level of education and nursing
experience will be collected from the participants (Appendix 1). Approximately 20 Semi-structured,
individual interviews will be conducted in a private conference room at the Children’s Hospital at MUSC,
or via phone or videoconference according to participants’ preference, with the investigator utilizing an
interview guide (Appendix 2). Open-ended interview questions will explore nurses’ perceptions of
barriers and enablers to implementation of nonpharmacological nursing interventions for infants with
NAS (Appendix 2). The interview guide is designed to yield information related to nurses’ perceptions
and experiences with caring for infants with NAS; factors they believe impact the infant’s length of stay;
efficacy and effectiveness of withdrawal scoring instruments; and nurses’ perceptions of mothers’
responses and interactions with her infant. All interviews will be audio recorded, transcribed using an
MUSC-approved transcription service, and entered into NVivo12 software for coding and analysis.
F.8. Data Analysis
The PI will collect data from a number of sources to address the study aims. Interview transcripts will
be compared against original recordings to ensure accuracy. Data from participant interviews will be
analyzed using conventional content analysis and NVivo12 qualitative data analysis software to code
data into common themes. With the TDF as an initial coding framework, the PI will use the constantcomparative method throughout the process of data analysis until theoretical saturation has occurred.
The expected outcome of qualitative descriptive studies is a straight, descriptive summary of
informational contents of data organized in a way that best fits the data (chronologically by topic, by
relevance, etc.) (36). Analytic strategies include: a) coding of data from notes or interviews b) recording
insights and reflections on the data c) sorting through the data to identify similar phrases, patterns,
themes, sequences, or important features d) looking for commonalities and differences among the data
and extracting them for further consideration and analysis e) gradually deciding on a small group or
generalizations that hold true for the data f) examining these generalizations in the light of existing
knowledge (37).
Data from the demographic surveys will be stored within REDCap and exported to SPSSv22 for
analyses. Descriptive statistics will be used to provide basic information about the variables in the
dataset and highlight potential relationships between the quantitative and qualitative samples.
Descriptive statistics such as, frequency distributions, measures of central tendency (mean, median),
and measures of dispersion or variation will be computed on the demographic characteristics (gender,
age, race/ethnicity, and level of education and nursing experience) and of the study participants.
Aim #2: To measure nurses’ perceptions of barriers and enablers to implementation of
nonpharmacological nursing interventions for infants with NAS using a tailored Determinants of
Implementation Behavior Questionnaire (DIBQ-NAS).
Introduction: We expect that the demographic survey and DIBQ-NAS will be completed by
approximately 400 members of NANN, an approximate response rate of 22%, over the course of 4-6
months. For a 95% confidence interval with a standard deviation of 0.5 and ± 5% margin of error, 367
members of NANN will be needed based on an approximate membership of NANN of 8200 (38). A link
to the demographic survey and DIBQ-NAS, administered through REDCap via email, will be sent to the
entire membership of NANN; however, initial questionnaire screening will likely reduce the study
sample to those who have at least 6 months of experience caring for infants with NAS. A screen, prior
to navigating to the surveys, will allow the member to consent to participating in the study. The
demographic survey and DIBQ-NAS are expected to take approximately 10 minutes to complete.
F.9. Setting
Study participants will be recruited through NANN, a professional organization of registered nursing
professionals at all stages of their careers who care for newborn infants born with a variety of health
challenges, including prematurity, birth defects, infection, cardiac malformations, and surgical problems.
In addition, participants enrolled in the quantitative component (Aim #2) will have the opportunity to
participate in the qualitative component (Aim #1).
F.10. Sample
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A database will be developed in REDCap that will include a demographic survey and the DIBQ-NAS.
The link to the demographic survey and DIBQ-NAS will be sent via email to more than 8,200 members
of NANN using the NANN Listservs resource. Approximately 367 NANN members will be needed to
complete the survey given a 95% confidence interval with a standard deviation of 0.5 and ± 5% margin
of error (confidence interval) (38). Additional interview participants for Aim #1 will be recruited through
the REDCap survey by providing the interested member the option to participate in an interview.
Table 2 – Inclusion and Exclusion Criteria
Inclusion Criteria

Exclusion Criteria

Nurses must be members of NANN, self-report
having at least 6 months’ experience caring for
infants with NAS, and have access to a computer
with a valid email address (for purposes of
completing survey instrument via REDCap).
F.11. Eligibility and Recruitment
Members of NANN will be sent a demographic survey and DIBQ-NAS, administered through REDCap
via email, requesting participation by completing the surveys. While there are over 8200 members of
NANN currently, the PI will aim to collect data from approximately 367 completed surveys (see Table
2). The DIBQ-NAS will conclude with an option for nurses to express interest in completing a telephone
interview with the PI. Pending study funding, participants completing the DIBQ-NAS will be entered into
a drawing to receive 1 of 6 $25 gift cards.
F.12. Data Collection
To design effective strategies to improve nurses’ implementation behaviors, a valid and reliable
questionnaire is needed to assess potential implementation determinants (39). The DIBQ was
developed to measure the potential behavior determinants of the 12-domain version of the TDF (40).
The initial DIBQ contained 100 items assessing 12 domains. Results obtained from confirmatory factor
analysis and Cronbach’s alpha resulted in the DIBQ consisting of 93 items assessing 18 domains,
explaining 63.3% of the variance, and internal consistency reliability values ranging from .68 to .93.
Domains demonstrated good discriminant validity, although the domains Knowledge and Skills, and
domains Skills and Social/professional Role and identity were highly correlated. The DIBQ, although
thorough, is long and tedious and may deter potential participants from completing it.
The PI will utilize a tailored, more succinct version of the DIBQ (Appendix 3) in the proposed study.
The tailoring of the DIBQ will be completed by the PI and informed by findings from the integrative
review in which Knowledge, Skills, and Social/Professional Role and Identity were identified as the
most influential domains relevant to modifying healthcare providers’ behaviors regarding the
implementation of nonpharmacological interventions aimed at decreasing the LOS for infants with NAS.
However, in addition to these 3 domains, other influential contextual and environmental domains will be
incorporated into the tailored version of the DIBQ. The original developers of the DIBQ designed the
questionnaire to be easily adaptable so it can be used in studies investigating implementation
behaviors performed by other healthcare providers in other settings (39). The DIBQ-NAS will consist of
11 questions pertaining to the Knowledge, Skills, Organizational Resources and Support, Innovation
Strategies, Perceive Behavioral Control, and Social Support of nurses who care for infants with NAS
and their families. The DIBQ-NAS will utilize an ordinal scale to approximate interval properties, such
as Likert-type responses to measure nurses’ perceptions regarding implementation of
nonpharmacological nursing interventions for the infants with NAS. A consistent variable coding
strategy will be developed for item responses where lower values represent less confidence/agreement
and higher values represent greater confidence/agreement. The DIBQ-NAS is designed to yield
information related to the influential constructs and domains of the TDF relevant to modifying nurses’
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behaviors regarding the implementation of nonpharmacological interventions aimed at decreasing the
LOS for infants with NAS.
F.13. Data Analysis
Rigorous quantitative data analysis procedures will include: a) preparing the data for analysis b)
exploring the data c) validate the tailored questionnaire d) analyzing the data e) representing the data
analysis f) interpreting the results and g) validating the data and results (41).
The PI will conduct an exploratory factor analysis (EFA) on the DIBQ-NAS to empirically identify
dimensionality of the TDF Constructs (Knowledge, Skills, Organizational Resources and Support,
Innovation Strategies, Perceive Behavioral Control, and Social Support) utilized in the DIBQ-NAS. The
first phase of the EFA will involve transforming the raw data matrix into a correlation matrix to ensure it
is factorable, to determine if there are missing data problems that need to be resolved, implement mean
or median item imputation if required, and to ascertain that the sample size is adequate (42). The next
phase will include identifying the appropriate extraction method (i.e., maximum likelihood) to determine
the number of factors needed to adequately capture the variance in the set of variables (43). The third
phase includes determining how many factors to retain. This phase will likely include the use of oblique
rotation (i.e., direct oblimin), scree plots, and multiple test runs to determine how many meaningful
factors will be in a data set (43). The fourth phase includes determining the method of rotation to
transform the original factors so that the results are more interpretable. The final phase will involve
interpreting, evaluation, and refining the factors (43).
Preparing the data for analysis will include cleaning data entry errors from the database, and
implementing appropriate data analysis procedures when applicable, such as mean or median item
imputation, depending on the importance and pattern of the missing data. Exploring the data involves
visually inspecting the data and conducting a descriptive analysis (the mean, standard deviation, and
variance of responses to each item on the instrument) to determine the general trends in the data.
Analyzing the data will involve choosing the appropriate statistical test; analyzing the data to answer the
research questions, report inferential test, effect sizes, and confidence intervals: and using quantitative
statistical software (SPSSv22) programs (41).
In addition, assuming normal distribution, the PI will conduct an analysis of variance (ANOVA), a
bivariate parametric test, to draw inferences about differences among the study participants and to
determine construct validity of the DIBQ-NAS. However, when comparing only two groups (i.e., gender)
the t-test will be used. The independent variables are the demographic characteristics of the
participants (i.e., gender, age, race, and level of education and nursing experience), and the dependent
variables are the domains and constructs of the TDF (i.e. Knowledge, Skills, Organizational Resources
and Support, Innovation Strategies, Perceive Behavioral Control, and Social Support) as they relate to
nurses who care for infants with NAS and their families. Further, the PI will conduct chi-square tests to
determine inferences regarding the relationship between categorical variables. If the sample size is too
small, or determining if the proportions of one variable are different depending on the value of the other
variable, a Fisher’s exact test will be utilized.
Data from the DIBQ-NAS and the demographic surveys will be stored within REDCap and exported
to SPSSv22 for analyses. In addition, demographic data collected during interviews will be manually
entered into REDCap and exported to SPSSv22 for analyses. Descriptive statistics will be used to
provide basic information about the variables in the dataset and highlight potential relationships
between the quantitative and qualitative samples. Descriptive statistics such as, frequency distributions,
measures of central tendency (mean, median), and measures of dispersion or variation will be
computed on the demographic characteristics (gender, age, race/ethnicity, and level of education and
nursing experience) and of the study participants.
The intent is to understand clinical and demographic characteristics of the participants and the
constructs of the TDF as they relate to the implementation of nonpharmacological nursing interventions
for infants with NAS.
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Aim #3: To merge the interview and DIBQ-NAS results to identify and prioritize barriers and
enablers to inform future implementation of nonpharmacological nursing interventions for
infants with NAS.
F.14. Data Collection
The findings from the demographic surveys, interviews (from Level 2 Neonatal Nursery nurses and
NANN participants), and DIBQ-NASs will be merged and analyzed. It is expected the results will allow
the PI to identify and prioritize barriers and enablers to inform future development of educational
programs for nurses aimed to facilitate implementation of nonpharmacological nursing interventions to
improve the care of the NAS maternal-infant dyad.
F.15. Data Analysis
The results from Aim #1 and Aim #2 will be merged. Data merging involves the joint review of both
data types to compare and contrast themes. The data for Aim #1 and Aim #2 will be collected
concurrently; however, the data will be independently analyzed using analytic approaches best suited
to the quantitative and qualitative research questions (Figure 2). A joint display will be the strategy used
to array both quantitative and qualitative data so that the two sources of data can be directly compared.
The themes that emerge from the quantitative and qualitative data will be categorized utilizing the
domains and constructs of the TDF.
Figure 2: Data Analysis of Convergent Parallel Design

F.16. Potential Problems and Alternative Strategies
This study has the potential to be affected by challenges such as inadequate sample size, inability to
coordinate interviews due to work schedules, participant fatigue, and erroneous data. In addition, there
is the potential for social desirability response bias (44) to exist, where participants answer questions
with a response they feel is more socially acceptable. To mitigate these challenges, the PI will provide
an introduction to the study and extend invitations to participate via multiple venues, such as employee
group emails, flyers located in staff areas, monthly staff meetings, and the NANN Listservs database. In
addition, the PI will schedule the demographic surveys and interviews at the convenience of the
participant, to be completed in person, in a private conference room located in the Children’s Hospital
at MUSC, or via phone or videoconference according to participants’ preference. The PI will protect
participants against financial risks by carefully scheduling interviews so that work is not interrupted. In
addition, the interviews will take approximately 45 minutes to complete and the DIBQ-NAS will take
approximately 10 minutes to complete to avoid participant fatigue. The PI will also employ the strategy
of creating rapport with the participants, using a comfortable environment conducive to interviews, and
educating the participant about the study and how the information collected will be used (44). By
mentioning that there is no right or wrong answer and that the data will be carefully secured, the PI will
also give participants permission to respond honestly (44). To mitigate the incorporation of incomplete
or missing data from the DIBQ-NAS, which may skew results, the PI will implement appropriate data
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analysis procedures when applicable, such as mean or median item imputation, depending on the
importance and pattern of the missing data.
F.17. Timeline
Table 3 includes the anticipated timeline for completing the primary objectives for the proposed
study: IRB approval, participant recruitment, data collection, data analysis, manuscript preparation, and
submit for publishing. Aim #1 and #2 will be conducted concurrently.
Table 3 – Proposed Study Timeline
Primary Objectives
• Obtain IRB approval for proposed study
• Participant recruitment
• Data collection
• Data analysis
• Manuscript preparation
• Submit compendium

Anticipated Date of Completion
• 6/2018 – 7/2018
• 8/2018 – 1/2019
• 8/2018 – 1/2019
• 8/2018 – 1/2019
• 2/2019 – 3/2019
• 4/2019

G. Human Subjects
G.1. Risk to the Subjects
a. Human Subjects Involvement and Characteristics
Study participants for Aim #1 will be recruited from the Level 2 Neonatal Nursery of the NICU at
MUSC. The NICU at MUSC currently employs over 200 nurses and is a state-designated regional
perinatal center, providing comprehensive care to healthy and critically ill newborns throughout the
state.
Purposeful sampling will be used to recruit participants who have experience caring for infants with
NAS and their families. The intent will be to obtain a diverse sample of participants with regard to
gender, age, race/ethnicity, level of education, and nursing experience. For this study, the PI will
attempt to recruit up to 20 participants for interviews until theoretical saturation is achieved. The PI will
recruit nurses who have at least 6 months of experience caring for infants diagnosed with NAS (Table
1). The interviews will be conducted in person, in a private conference room located in the Children’s
Hospital at MUSC, or via phone or videoconference according to participants’ preference.
For Aim #2, participants will be recruited through NANN, a professional organization of registered
nursing professionals at all stages of their careers who care for newborn infants born with a variety of
health challenges, including prematurity, birth defects, infection, cardiac malformations, and surgical
problems. Interview participants will be recruited from the Level 2 Neonatal Nursery of the NICU and
members of NANN who have completed the DIBQ-NAS and selected the option to participate in an
interview.
A survey conducted by the National Council of State Board of Nursing (NCSBN) in 2015 indicated
that of US nurses, 14.1% were male, 19.5% identified themselves as a racial/ethnic minority, 42% had
a bachelor of science in nursing (BSN) as their initial credential, while 65% obtained a baccalaureate or
higher degree (in any field) as their highest level of education (45). The intent of this study is to obtain a
diverse sample of participants with regard to nurses’ gender, age, race/ethnicity, and level of education
and nursing experience. The targeted enrollment for this study is representative of the demographics of
US nurses identified in the 2015 NCSBN survey.
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Targeted/Planned Enrollment Table: Nurses
Total Planned Enrollment: 387 Participants
TARGETED/PLANNED ENROLLMENT: Number of Subjects
Sex/Gender
Ethnic Category
Females
Males
Hispanic or Latino
6
3
Not Hispanic or Latino
326
52
Ethnic Category: Total of All Subjects*
332
55
Racial Categories
American Indian/Alaska Native
0
0
Asian
20
3
Native Hawaiian or Other Pacific Islander
0
0
Black or African American
33
5
White
273
44
Racial Categories: Total of All Subjects*
326
52

Total
9
378
387
0
23
0
38
317
378

Inclusion of Women and Minorities
Both women and minorities will be included in the proposed study. However, the Level 2 Neonatal
Nursery at MUSC (recruitment site for Aim #1) currently employs 2 male White nurses and 4 female
African American nurses. The intent for Aim #2 is to gain participant diversification and minority
participation through the use of the NANN membership Listservs database.
b. Sources of Materials
The only sources of research-related information obtained from human subjects are described in the
above research proposal. Data sources include:
• Audio recordings, transcriptions, and field notes from interviews.
• De-identified electronic data from survey information recorded in REDCap.
All data will be used specifically for research purposes. Every effort will be made to keep study
records confidential. No identifiers will be used in any reports or publications resulting from this study;
however, the data may be used in future studies.
c. Potential Risks
Although we do not expect any significant risks related to the completion of the surveys and
interviews in this study, it is possible a participant may experience emotional distress while completing
the survey and interview. If necessary, protection against psychological or emotional distress will be
provided through debriefing sessions following interviews. In the case of psychological or emotional
distress that is not relieved by debriefing, the PI will arrange a referral to a psychologist or psychiatrist.
In addition, the participant may choose to discontinue participating in the study at any time. The PI
conducting the interviews will monitor the participant for signs of distress and appropriate follow-up will
be provided to identify any serious psychological concerns. In the event of a life-threatening
emergency, the investigator will call 911.
G.2. Adequacy of Protections Against Risks
a. Recruitment and Informed Consent
For Aim #1, registered nurses who have at least 6 months’ experience caring for infants diagnosed
with NAS will be invited to participate in this study. For Level 2 Neonatal Nursery nurses, invitations to
participate will be extended via employee group emails, flyers located in staff areas, and monthly staff
meetings. Additional interview participants will be recruited through the DIBQ- NAS. Members of NANN
will indicate their willingness to participate in a phone or videoconference interview with the PI by
selecting an option at the end of the questionnaire. The PI will be notified via REDCap of a participant’s
interest in completing an interview. The PI will contact the interested member via email or phone to
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complete the eligibility screening process. Interview participants will be enrolled on a first come, first
served method.
For Aim #2, registered nurses who have at least 6 months’ experience caring for infants diagnosed
with NAS and have access to a computer with a valid email address will be invited to participate in this
study. Participants will be recruited through NANN using the Listservs resource. Members of NANN will
be sent a demographic survey and DIBQ-NAS, administered through REDCap via email, requesting
participation by completing the surveys. The DIBQ-NAS will conclude with an option for nurses to
express interest in completing a telephone interview with the PI.
The PI will seek a waiver of signed consent, since no interventions are being performed. The
Information for Interview/Survey Participants document (see Appendix 4 and 5, respectively) will be
provided to participants and will describe the study objectives and contain all other required elements of
consent. The document also notes what topics will be discussed, how long the survey/interview process
should take to complete, and assurance of confidentiality. The PI has received adequate training in
human subject protections, including Miami CITI training. Prior to their inclusion in the study,
participants will be informed about the details of the study procedures and protocol as well as the risks
involved with participating. Participants will also be informed that they are free to withdraw from the
study at any time.
For interview participants, before protocol-specific procedures commence, the PI will fully explain
the aspects of healthcare provider privacy concerning research specific information. Each participant
and consenting professional will receive an information sheet regarding the study. For participants
completing the DIBA-NAS, the first screen of the survey will include the study information for
participants and they can select the option to continue to the survey or disagree to exit the survey. All
participants will be reminded that every effort will be made to maintain their confidentiality and that they
may refuse to participate in the study or withdraw at any time without explanation, and that such an
action will in no way affect their status as an employee of MUSC and/or membership with NANN.
b. Protection Against Risk and Data Management
Minimal risk is anticipated for this proposed study. In the event of an unexpected event as a result of
participating in the surveys and/or interviews, the participant will be instructed to contact the PI. Based
on the study design, it is anticipated that the risk of adverse events (AE) will be acceptably low to nonexistent. However, in the event of an AE, it will be recorded and reported to the IRB and investigator
according to institutional requirements and procedures. The PI’s doctoral advisor will review all AEs.
Several plans are in place for protection of participant confidentiality. The Information for
Interview/Survey Participants document (Appendix 4 and 5) assures confidentiality of all information
obtained during the study. Confidentiality of participants will be protected by conducting interviews in a
private location that will be secured by the investigator prior to the scheduled interview. The confidential
data will be de-identified for transcription and analysis. Each participant will be assigned a case number
to be referenced on study instruments. The participant identification and enrollment log will also be
confidential and filed by the PI in the study file. To ensure participant confidentiality, no paper copies
will be made. All reports and communications related to the study will identify participants by assigned
case number. All data will be stored in a secure, password-protected REDCap database, in accordance
with MUSC’s data storage requirements, and the passwords to those files will be accessible to the PI
and the PI’s doctoral advisor only.
No personal identifiers will be collected; however, email addresses and telephone numbers may be
used for the purposes of contacting participants to schedule interviews or to send surveys. Participant
contact information will not be connected to any data, and it will be discarded after interviews and
surveys have been completed. Breach of confidentiality may be considered an AE, and will be reported
to the IRB.
Audio recordings of interview sessions will be uploaded from a portable recorder to passwordprotected MUSC network storage after which the recordings will be deleted from the portable recorder.
Transcription of audio recorded interviews will be conducted by an MUSC-approved transcription
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service. The PI will store all transcribed data and study-related documents in a fingerprint-protected
safe that will only be accessed by authorized personnel. Data obtained during interviews will be stored
in a locked location, accessible only to the PI and doctoral advisor. In addition, caution will be used
when presenting interview findings. The intent is to provide adequate quotes and raw data to elicit thick
descriptions while avoiding unintentional disclosure of participant identity. Digital audio recordings of
interviews will be stored in a secure electronic database for a minimum of 6 years.
There are no social or legal risks associated with participating in this study. Significant efforts will be
undertaken to ensure the safety of all participants. The PI will protect participants against physical risks
by observing for fatigue and providing breaks when needed. If a participant feels she/he cannot
continue with the interview, the interview session will be rescheduled. Participants will be protected
against financial risks by scheduling interviews so that work is not interrupted. In the event of studyrelated illness or injury, participants will be instructed on how to access health care. Participants will be
given an information sheet with the PI’s name and phone number to contact in the event that there is a
problem or if the participant has study-related questions.
G.3. Potential Benefits of the Research to Subjects and Others
Participants will receive no direct benefit from the study. However, the disclosures of the participants
will inform future development of educational programs for nurses aimed at facilitating the
implementation of nonpharmacological nursing interventions to improve the care of the NAS maternalinfant dyad. The benefits outweigh the potential inconvenience to the participants in terms of
anticipated new knowledge gained from this study.
G.4. Knowledge to be Gained
The findings from this study will provide valuable information with the purpose of identifying barriers
and enablers to nurses’ implementation of nonpharmacological nursing interventions. These findings
will also inform the future development of educational programs for nurses that focus on a) the
implementation of nonpharmacological nursing interventions, such as, effective infant screening,
withdrawal assessment, and utilization of abstinence scoring tools and b) adult substance use, caring
for the maternal-infant dyad, and promoting nurse-mother relationships, all of which have been shown
to reduce withdrawal severity, LOT, LOS, hospital costs, while enhancing maternal self-efficacy in
caring for her infant and improving the care of this vulnerable and rapidly-growing patient population.
G.5. Subject Safety and Minimizing Risks (Data and Safety Monitoring Plan)
The PI will ensure safeguarding of the data through the following actions:
• Weekly tracking of subject accrual (enrollment, demographics)
• Timely and appropriate reporting of protocol deviations, privacy breaches, conflicts of interest,
or changes in personnel
• Ongoing daily monitoring of secure data storage
The PI will be responsible for monitoring the study and complying with reporting requirements. The
mentoring team will meet with the PI bi-weekly to provide oversight to ensure data safeguarding.
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